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Antibody Genetics
Charles K. Cole
Abstract
Antibodies are created through a unique mechanism whereby different gene 
segments at the antibody loci are semi-randomly recombined to form functional 
antibody genes. This process allows that adaptive immune system to generate 
protection against a near-infinite array of pathogens, however it presents unique 
challenges from a sequencing prospective. I present three projects addressing 
problems facing the repertoire sequencing community including a method for full-
length antibody transcript sequencing, a method for heavy and light chain pairing in 
single B cells, and a method for generating repertoires as a byproduct of a general 
polyA RNA sequencing protocol.
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Antibody Genetics
The purpose of the Immune system is to allow the body to discriminate between self
and non-self. This enables the body to detect and neutralize viruses, bacteria, fungi,
toxins and, in some situations, even cancer. In Vertebrates, this system can be
divided   into   two   mutually   supporting   but   conceptually   distinct   parts:   innate   and
adaptive immunity. The innate immune system is genetically encoded in the germline
and operates by recognizing evolutionarily-conserved patterns in biomolecules which
indicate the presence of harmful organisms. The adaptive immune system must
learn to recognize   pathogens through patterns in protein structure and is, on the
whole, slower than the innate immune system, taking several days for the response
to occur as opposed to several hours. However, once pathogens are recognized, the
adaptive immune system can retain life-long memory of them  and provide quick and
effective response to future infections.
The adaptive Immune system can be thought of as a chain of responses
which start when dendritic cells or macrophages - professional antigen presenting
cells engulf the pathogen-associated proteins. These proteins are then fragmented
into   smaller   peptides   and   presented   on   the   cell   surface   as   part   of   the   Major
Histocompatibility Complex (MHC2). These peptide fragments are called antigens
and,   when   presented   with   the   correct   co-stimulatory   factors   and   in   the   correct
context, will initiate an immune response by activating CD4+ and CD8+ T cells.
Those   possessing   a   T   cell   receptor   (TCR)   specific   to   one   of   the   antigens   will
continue to proliferate and drive further action by the immune system. CD8+ T cells,
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also known as Cytotoxic CD8+ T cells, serve an important role by migrating to the
site of infection and killing infected cells. CD4+ T cells, on the other hand support
immune response in two important capacities. In their first capacity, they produce
cytokines and chemokines which attract CD8+ T cells, Natural Killer cells and other
immune cells to the site of infection. In their second capacity they initiate the B cell
response by activating B cells in  the  germinal centers of the lymph nodes and
spleen.
A Brief History of Antibody Genetics
The precise moment that B cells  were discovered is somewhat debatable because
antibodies and the B cell response were discovered before the cell population was
isolated. In 1908 Paul Ehrlich received the Nobel prize for the discoveries he made in
the field of immunology and specifically for his work on vaccine development. In his
work   he   characterized   the   production   and   interaction   between   “toxins”   and
substances capable of neutralizing those toxins which he referred to as “antibodies”.
He noted that antibodies effective against one toxin would be ineffective against
another. From these results he developed the “lock and key” theory of antibody
specificity, wherein each antibody is specific to a particular antigen. In 1958 G. J. V.
Nossal published a set of experiments where the individual lymph node cells from
rats   immunized   with   one   or   both   of   two   strains   of   salmonella   were   isolated   in
microdroplets along with one or both strains. He noted that each lymph node cell
could inhibit one strain or the other but never both. This led to the theory that each
antibody-producing cell could produce only one antibody. 
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Antibody   proteins   were   first   isolated   by   Kabat   et   al.   in   1938   by   gel
electrophoresis of the protein component of antibody-containing sera before and
after mixing with antibody-sequestering antigen. He noticed that the sequestered
sample was missing the band at ~150kd, which he dubbed the -globulin. In 1961  𝝲
Edelman published a paper describing how the -globulin protein dissociated into  𝝲
two components under reducing condition, a large protein dubbed the heavy chain at
~50kd and a small protein dubbed the light chain at ~25kd. A simple calculation
revealed that antibodies were likely to consist of two heavy and two light chains.
Further mysteries emerged when it was revealed that the amino acid composition of
these chains are variable and that this variation was present at NH2 end of the
peptide but not the COOH end.
 In 1965 Bennett published a paper describing what was then considered to
be a fundamental paradox: How is it possible for one gene to produce an endless
variety of protein products with this unique pattern of mutations?  Bennet argued that
the conserved domain was the product of a single gene while the variable portion
was the product of a different set of genes and that the proteins were a product of
homology-based binding between these two parts. It was quickly determined that it
would be impossible for each unique antibody to be the product of a different gene
since the genome did not possess enough physical space to accommodate enough
antibody   genes   to   offer   the   near-limitless   level   of   protection   against   pathogens
observed thus far. In addition, a comparison of Human, Mouse and Rabbit antibodies
indicated   an   evolutionary   pattern   which   would   be   impossible   to   replicate   via
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thousands of independently evolving genes. In 1967 smithies proposed a genetic
model whereby there existed a single heavy, kappa, and lambda gene, but for each
gene there existed and associated “scrambler” gene which annealed to the variant
half of the “master” gene during DNA replication, inducing somatic mutations. Leroy
Hood came close to realizing the truth when, in 1970, he proposed a model where
the constant and variable regions of each chain where encoded by two separate
classes of genes and then combined to form the complete antibody (McKean, Bell,
and Potter 1978). M. Weigert noted that variants present in the variable region of
Lambda chains were more likely to occur inside three “specificity” regions of the
chain. He postulated that many of these mutations were likely to be the result of
somatic variants and that they were driven by the antigenic specificity of the antibody
and that the true number of variable segment genes was much lower than what had
been previously proposed (Weigert et al. 1970). 
In 1976 Hozumi et al in the lab of Susumu Tonegawa published a paper
describing   a series  of   experiments  wherein  radio-labeled   whole   and  fragmented
kappa  chain  RNA  was  hybridized  to  restriction-digested  embryonic  and
plasmacytoma DNA from mice (Hozumi and Tonegawa 1976). He noticed that whole
and 3’ fragments of RNA hybridized to a single band in the plasmacytoma DNA while
in embryonic DNA the whole RNA hybridized to two different bands and the 3’
fragments hybridized to the larger of those two bands. He hypothesized that these
patterns appear because the kappa chain gene exists as two separate and remote C
and V genes in the germline but are joined together through somatic rearrangement
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in   antibody-producing   cells.   One   year   later,   direct   visualization   of   kappa   mRNA
hybridization   to   myeloma   DNA   by   electron   microscopy   indicated   that,   in   the
rearranged genome, the C and V genes were 1250bp apart (Brack and Tonegawa
1977). Further experiments on the Lambda chain genes revealed the presence of an
extra antibody gene segment between the C and V segments which had up to that
point remained undetected and which they called the J segment (Brack et al. 1978).
Hood   et   al.   identified   via   sanger   sequencing   a   third   segment   involved   in   the
rearrangement of heavy chain genes which he called the D segment  (Early et al.
1980). In addition, he identified a set of conserved noncoding sequences 3’ to the V
segment   and   5’   to   the   J   segment   which   consist   of   nearly   identical   7   and   10
nucleotide sequences separated by either 11 or 22 nucleotide spacer consisting or
random nucleotides. Furthermore, the conserved sequences at the 3’ of the V and 5’
of the J are nearly inverse complements of one another. Hood correctly hypothesized
the   presence   of   a   protein   which   would   recognize   these   sights   and   initiate
recombination.
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Diagram of Antibody Genetics (Tonegawa 1983)
 L. LuzzatI studied the phenomena of multi-class expression whereby B cells
express heavy chains which are identical except for the constant region  (Pernis,
Forni, and Luzzati 1977). He observed patterns in Isotype expression of LPS-treated
lymphocytes   which   suggested   that   all   cells   start   out   with   the   ability   to   produce
simultaneous   IgM   and   IgD   and   gradually   transition   over   to   producing   IgG.   The
complete picture would be revealed by Kataoka with the allelic deletion model(Honjo
and Kataoka 1978). Hybridization experiments revealed that myeloma tumor cells
had different copy numbers of different IgG alleles depending on which Isotype they
produced. He observed that cells which produced IgG1 had half as many copies of
IgG3, and that cells which produced IgG2b had half as many copies of both IgG3
and IgG1. Patterns such as these led him to the conclusion that class-switching
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occurs by deletion of the constant region genes between the Variable segment and
the new class.
In 1989, the Recombination Activating Gene(RAG-1) was isolated  (Schatz,
Oettinger,  and   Baltimore   1989).   This   was   the   first   gene   proven   to   confer
recombination   activity   at   Recombination   Signal   Sequences(RSS)   sites.   It   was
detected by repeated fragmentation and transfection of DNA from a cell line with high
recombinase activity into a non-recombining cell line and then plating on media
which selected for recombination activity. The transfected DNA was ligated along
with   a   small   oligo   which   the   experimenters   used   as   a   priming   site   for   sanger
sequencing. Further experiments revealed that RAG-1 was evolutionarily conserved
to the point where Human RAG-1 cDNA could be used as a probe to detect the
RAG-1 genes in mouse, horse, goat, rabbit, and dog as well. One year later RAG-2
would be discovered, a neighboring gene which, in combination with RAG-1, initiate
efficient recombination at RSS sites(Oettinger et al. 1990). 
By this point it was understood which genes were needed for recombination
to occur, however this was not the full story. It was known that nucleotides were
incorporated at the sites of recombination which could not have originated from any
of the available gene segments. In addition, it was known that the heavy and light
chain genes  could mutate during cell  replication.  In 1993 the results of several
knockout   experiment   showed   that   an   absence   of   Terminal   deoxynucleotidyl
transferase expression eliminated the incorporation of non-template nucleotides at
the   CDR3  (Komori   et   al.   1993).   a   few   years   later   Activation-induced   cytidine
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deaminase was shown to be necessary for both somatic hypermutation of antibody
genes and class-switch recombination (Muramatsu et al. 2000) and finally, In 1998, a
complete copy of the Human Heavy Chain locus was assembled(Matsuda et al.
1998). The ~1.4 Mb locus is notable for being internally repetitive and for containing
numerous V segment pseudogenes.
Modern understanding of antibody genetics
In combination these studies laid the groundwork for our current understanding of
how the unprecedented diversity of antibody proteins.
In summary: 
1.) Each B cell produces an antibody which consists of a pair of unique heavy chains
and light chains, each of which can be divided into a variable and constant region. 
2.)   The   Variable   region   of   heavy   and   light   chains   consist   of   3   Complementary
Determining   Regions(CDRs)   which   determine   antigen   binding   and   3   Framing
Regions(FRs) which give the antibody structure. At the mRNA level, the variable
Variable region occurs at the 5’ end of the transcript with the CDRs sandwiched
between the FRs. CDR1 and CDR2 are inherited from the  V gene segment while the
CDR3 is a product of somatic recombination.
3.) During somatic recombination, one V, D (heavy chain only), and J gene segments
are randomly selected from a collection of segments in the respective gene locus.
These segments are recombined into a variable region. During this process   non-
template   nucleotides   are   added   between   the   gene   segments   and   nucleotides
removed via chewback, generating large amounts of sequence diversity. 
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4.)   Further   diversity   is   generated   through   somatic   hypermutation   during   affinity
maturation and clonal expansion. This process generates a lineage of antibodies
which share a common parent but which may possess distinct mutations which affect
their ability to bind to antigens. Antibodies with higher affinity to the target antigen will
divide faster, driving the production of antibodies with increasing affinity. 
5.) The constant region consisted of a single isotope-determining gene segment
which   could   be   expressed   in   either   the   membrane-bound   or   secreted   form.   In
addition, the isotype of an antibody could change due to isotype switching. The
isotype influences the type of receptors the antibody binds to and the multiplicity of
the antibody in its secreted form.
High-throughput sequencing to investigate antibody transcripts
One of the primary technical challenges which faced early antibody 
geneticists  was figuring out the sequence of distinct antibodies. Sanger sequencing 
was the method of choice for most scientists and this method required two things: 1. 
A pure DNA template 2. A known priming site on the template. However, any mRNA 
or cDNA sample derived from a healthy population of B cells will contain contain a 
mixture of distinct antibody transcripts. Thus, many early studies were done using 
lymphoma antibodies. Lymphoma are often derived from a single B cell which means
that the antibody transcripts derived from the cancer will be relatively pure. Cloning 
enabled the isolation of individual antibody transcripts, however this method was 
time-consuming and low-throughput. 
Unfortunately, the advent of high-throughput sequencing didn’t help address this 
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challenge. Regular RNAseq protocols would not allow for the identification of distinct 
heavy and light chains in bulk samples. Because portions of a sequence would be 
shared between different antibodies while other portions would be unique, it would 
be impossible to reconstruct antibodies using an Overlap-Layout-Consensus(OLC) 
or debruijn graph assemblers, which rely on the fact that sufficiently large stretches 
of the target sequence are unique and can be identified by alignment or k-mer 
analysis. In fact, the only difference between two independently-generated antibody 
transcripts may be as small as one nucleotide! Thus, any bulk repertoire sequencing 
approach would have to generate reads which would both cover the entire variable 
segment and also be grouped by the original molecule which the sequence was 
derived from. 
In 2011 a method for high-throughput sequencing of antibody repertoires was 
published (Weinstein et al. 2009). In this study, cDNA amplicons were generated 
from Zebrafish mRNA by priming off of the second framing region and the constant 
region in heavy chain transcripts and then sequencing using 2x230 runs on the 454 
pyrosequencer. These sequences would cover the entire V segment and a portion of
the C segment using two paired reads which could be reconstructed into an antibody
transcript by OLC assembly. This provided enough information to identify the isotype 
and clonality of the heavy chains in a small population of zebrafish. The authors 
found that the recombination rate for different gene segments varied dramatically 
and that the rate of V segment usage varied significantly between individuals. That 
same year a paper was published showing that repertoire sequencing could be used 
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to detect minimal residual disease in patients with CLL. The authors showed that 
high-throughput sequencing of heavy chains in patients with CLL could readily 
identify the presence of cancer-derived antibody clones (Logan et al. 2011). In 2012 
repertoire sequencing was applied to the problem of haplotyping the human heavy 
chain locus (Kidd et al. 2012). The authors did this by taking advantage of the fact 
the J6 is the most commonly used J segment and that if someone is heterozygous 
for J6 then heterozygous V and D segments will segregate with one copy of J6 or the
other when V(D)J recombination occurs. These patterns can be used to phase gene 
segments in the heavy chain locus. Soon after it was demonstrated that repertoire 
sequencing could be used to measure the adaptive immune response through 
detection of heavy chains conserved across multiple administrations of influenza 
vaccine (Vollmers et al. 2013). In 2013 repertoire sequencing was used to identify 
novel HIV neutralizing neutralizing antibodies. Repertoires were generated from 
HIV+ patients and sequences compared to known HIV neutralizing antibodies using 
phylogenetic analysis. This method was capable of identifying antibodies with low 
sequence homology but strong comparable HIV neutralizing ability. Several years 
later it was shown that repertoire sequencing could be used to detect graft rejection 
in heart transplant patients undergoing immune suppression and that it was capable 
of detecting rejection sooner than the cell-free DNA assay which was widely 
considered to be the gold standard. It was found that graft rejection correlated 
strongly with the abundance of highly mutated antibody transcripts, especially IgG 
and IgA sequences (Vollmers et al. 2015).
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Even though Immune repertoire sequencing has been used successfully to answer 
basic and applied questions in immunology, there were still limitations with this 
technology that my work as a graduate student aimed to address.
Aims
Aim 1: Full Length Heavy Chain Sequencing
Heavy chain transcripts are typically somewhere between 1,500 and 2,000bp long 
depending on if they are membrane-bound or secreted. Furthermore, about 700bp 
needs to be sequenced in order to identify the complete variable region as well as 
enough the the constant region in order to identify isotype.  At the time this project 
was conceived, all published protocols for the sequencing of antibody repertoires 
involved priming off one of the conserved framing regions in the V-segment, leaving 
one or more of the CDRs unsequenced (Georgiou et al. 2014). The CDRs define 
what antigens will bind and with what affinity. If you want to study the antibody or use
it in a scientific or healthcare setting, you have to know the sequence of all the 
CDRs.  
To address these limitations, we set out to create a method for sequencing full-length
heavy chain transcripts. We accomplished this by using a combination of molecular 
indexing and random shearing via TN5 to generate a library where entire transcripts 
can be reconstituted practically error-free. 
Aim 2: Heavy and Light Chain Pairing
There are several billion B cells in each person’s blood and hundreds of billions of B 
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cells residing in a person’s lymphatic tissue, which means there are billions of unique
heavy and light chains which comprise an individual’s antibody repertoire. We can 
infer the amino acid sequences of a person’s heavy and light chains by sequencing 
the mRNA extracted from that person’s B cells. However, at the time this project was
conceived, it was impossible to know which pairs of heavy and light chains were 
produced by the same B cell without using single-cell sequencing. In 2015 DeKosky 
et al. published a method for isolating single B cells in droplets and generating Heavy
and Light chain amplicons which could later be sequenced (DeKosky et al. 2015). 
However, this method resulted in a high dropout rate which was likely due to the 
stochastic nature of isolating single cells using droplets. We were interested in 
pairing heavy and light chains for two reasons. From a practical point of view, you 
need to be able to pair heavy and light chains if you want to identify complete 
antibodies using repertoire sequencing and without the use of single-cell techniques. 
Thus, the development of an efficient and robust pairing technique would greatly aid 
in the expression and analysis of antibodies. In addition, pairing heavy and light 
chains would allow for the study of chain pairing patterns, biases and interactions.
We proposed that by taking a sample of B cells, dividing it into several smaller 
samples and sequencing each of these subsamples it is possible to discover heavy 
and light chain pairs which were present in the original sample. Our method calls for 
sequencing subsamples containing several thousand B cells and looking for heavy 
and light chain sequences which occur in multiple subsamples. Because the human 
body contains millions of B cells, each with their own unique heavy and light chains, 
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it is highly improbable that any particular heavy and light chain pair would be present 
in multiple libraries unless they were produced by the same clonal B cell population. 
This project sought to build upon the work done by Howie et al. in their 2015 paper 
on pairing alpha and beta T cell receptor subunits using a very similar method, only 
with heavy and light chains of the antibody (Howie et al. 2015). However, there are 
several important differences which make this project more difficult. The biggest 
difference is that the T cell receptors do not undergo somatic hypermutation. Thus, 
well occupancy can be determined for each alpha and beta subunit by simple 
sequence identity. Heavy and Light chains must first be clustered into lineages which
consist of clonally related sequences. In addition, the unequal expression of heavy 
and light chains increases the probability of antibody dropout and false discoveries.
By good fortune we developed another technology which proved to be the key to 
pairing heavy and light chains. Around the same time we were working on a method 
for sequencing the 5’ ends of transcripts in single cells. At the time, the available 
technology for single cell RNAseq only supported the sequencing of 3’ ends, and 
since the 5’ end contains information about the transcription start site having the 
ability to sequence them would be useful. We developed a simple protocol using 
poly-A selection and template-switch reverse transcription to generate cDNA 
molecules with distinct priming sites at the 5’ and 3’ ends, and then followed with 
tagmentation and amplification to generate libraries which cover the 5’ ends of 
transcripts. We applied this method to a population of B cells and found that the data 
could be used to generate paired heavy and light chains. As you may recall, the 
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variable region of the antibody is present at the 5’ end of the transcript. We found 
that, with sufficient depth of sequencing, this method provided enough coverage of 
that region to assemble the variable portion of heavy and light chain transcripts in 
individual B cells and also estimate their isotype and expression levels. In the end, 
we were able to pair heavy and light chains as a byproduct of a method we 
developed for the sequencing of the 5’ ends of transcripts in single cells which we 
refer to as TN5Prime.
Aim 3: Repertoire Sequencing Using the Oxford Nanopore
Although dedicated antibody sequencing protocols can be used to accurately 
characterize the repertoire from mRNA, a fundamental problem is that these 
methods must be used in conjunction with regular RNAseq in order to fully 
characterize the transcriptome of a population of B cells. However, we demonstrated 
in the TM5Prime paper that repertoires can be acquired as a byproduct of certain 
types of mRNA sequencing. We believe that the future of repertoire sequencing and 
analysis will be as a byproduct of the sequencing of whole transcriptomes. We 
demonstrate that this is possible by applying the previously published R2C2 method 
to bulk PBMC RNA. We show that this method can be used to comprehensively 
measure the transcriptomes of the cells in our population including antibody and T-
Cell receptor transcripts.
In the following chapters I will present work I have done towards meeting these 
research goals. The first two chapters will come in the form of published papers 
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detailing experiments and their results which meet the technical objectives of the first
two aims, and the final chapter will present unpublished results as well as a brief 
analysis. 
Aim 1: Full Length Heavy Chain Sequencing
[THIS SECTION ADAPTED FROM Highly Accurate Sequencing of Full-Length 
Immune Repertoire Amplicons using Tn5 enabled and Molecular identifier 
guided Amplicon Assembly](Cole et al. 2016)
Highly Accurate Sequencing of Full-Length Immune Repertoire
Amplicons Using Tn5-Enabled and Molecular Identifier-Guided
Amplicon Assembly
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Abstract
Antibody repertoire sequencing is a powerful tool to analyze the adaptive immune 
system. To sequence entire antibody repertoires, amplicons are created from 
antibody heavy chain (IGH) transcripts and sequenced on a high-throughput 
sequencer. The field of immune repertoire sequencing is growing rapidly and the 
protocols utilized are steadily improving, yet, thus far, immune repertoire sequencing 
protocols have not been able to sequence full-length immune repertoires including 
the entire IGH Variable region and enough of the IGH Constant region to identify 
isotype subtypes. Here we present a method that combines Tn5 transposase and 
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molecular identifiers for the highly accurate sequencing of amplicons longer than 
500bp using Illumina short read paired end sequencing. We then apply this method 
to antibody heavy chain amplicons to sequence the first highly accurate full-length 
immune repertoire.
   
Introduction
Antibodies are encoded by Heavy Chain (IGH) and Light Chains (IGκ/λ) loci which ) loci which 
undergo somatic recombination during B cell differentiation. In the heavy chain, VDJ 
recombination creates a highly diverse Complementarity Determining Region 3 
(CDR3) when randomly and imperfectly combining one each of ~40 V, ~30 D, and 6 
J segments. Heavy chain loci are further modified by somatic hypermutation and 
class-switch recombination. Somatic hypermutation introduces mutations and indels 
that can affect the binding characteristics of an antibody. Class-switch recombination
changes the antibody isotype by genomic rearrangement of the isotype-determining 
Constant regions (IgM, IgD, IgG1-4, IgA1-2, IgE). The isotype of an antibody 
changes the characteristics of an antibody like the ability to bind complement, pass 
the placenta, or bind certain Fc receptors. Together, VDJ recombination, somatic 
hypermutation, and class-switch recombination create a virtually unique IGH locus in 
every mature B cell clone.
Because every B cell clone is unique and can expand and mutate in response to an 
antigen, analyzing the repertoire of IGH transcripts in a blood sample provides 
insight into the composition and state of the adaptive immune system. Immune 
repertoire sequencing has so far been used in both basic and translational research. 
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In basic research it has been applied to estimate the absolute size of the B cell 
repertoire in humans, track the effect of aging on the immune system, investigate 
V,D, and J pairing, and haplotype phase the genomic IGH locus. On the translational
side it has been used to track immune response to diseases and vaccines, to track 
minimal residual disease in leukemia, and determine rejection events following organ
transplantation(Boyd et al. 2009; Vollmers et al. 2013; Jiang et al. 2013; Glanville et 
al. 2011; Arnaout et al. 2011; Meyer et al. 2013; Vollmers et al. 2015). All these 
studies rely on capturing the diversity of the IGH repertoire but are limited by current 
sequencing technologies and protocols. Therefore, they either: 1.) utilize long read 
platforms (454) which allow for the sequencing of the whole IGH variable region plus 
partial constant region(Glanville et al. 2011; Jiang et al. 2013; Boyd et al. 2009) but 
are often limited by high cost, lower throughput, and high error rates or 2.) utilize 
short read sequencers (Illumina HiSeq, Illumina MiSeq, IonTorrent PGM) which allow
for higher throughput at lower cost and error-rate but are limited by their short read 
length to sequence only part of the IGH Variable Region including the CDR3 
(Vollmers et al. 2013; Meyer et al. 2013). To provide complete information of an IGH 
repertoire an ideal full-length IGH transcript amplicon would be ~530bp in length, 
starting at the Leader exon and ending at 100bp into the Constant Region. Starting 
in the Leader exon, which does not encode for the final antibody protein, would 
ensure no bases in the Variable region are masked by primers, which would ensure 
the accurate identification of all V segment alleles. Ending 100bp into the Constant 
Region would provide enough sequencing information to distinguish all Isotype and 
subtypes, which is essential for allergy research.
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While an Illumina MiSeq 2x300 sequencing run theoretically allows for the 
sequencing of this ideal 530bp IGH amplicon, in practice declining base quality 
doesn’t allow for the sequencing of an amplicon longer than 450bp. Recently, several
groups have employed approaches utilizing molecular identifiers (UIDs) to improve 
sequencing accuracy which is essential to differentiate somatic hypermutation from 
PCR and sequencing errors (Vollmers et al. 2013; Shugay et al. 2014; He et al. 
2014). Further, several groups have developed protocols utilizing short read 
sequencers to sequence individual molecules exceeding the current raw read length 
of these sequencers. These protocols rely on inefficient steps in library preparation 
including Biotin pulldowns and intra molecular circulations (Hong et al. 2014; Hiatt et 
al. 2010; Wu et al. 2014; Rossano et al. 2009; Lundin et al. 2013). To overcome read
length, accuracy, and library preparation limitations, we developed Tn5 enabled 
Molecular Identifier guided Amplicon sequencing (TMIseq). TMIseq is based on a 
simple library preparation protocol utilizing molecular barcoding of individual 
molecules and Tn5 tagmentation (Picelli, Björklund, et al. 2014) enabling the highly 
accurate and cost effective sequencing of molecules exceeding Illumina read length 
(Fig. 1).
   
Results
Overview of TMIseq
To assemble RNA molecules that exceed the sequencing length but not the cluster 
generation length of Illumina sequencers, TMIseq utilizes molecular identifiers and 
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the unique characterisitics of the Tn5 enzyme. We reverse transcribe RNA molecules
into cDNA and then generate 2nd and 3rd strand copies of cDNA in a two cycle 
amplification reaction using two primer pools. The primer pools we used for to 
assemble IGH RNA molecules were: 1.) The V_Leader pool containing primers 
specific to the Leader exons of all V segments 2.) The C_long pool containing 
primers that bind 100bp into the Constant regions of all Isotypes (C_long). All 
primers in these pools feature modified 5’ ends to generate a single 3rd strand cDNA
copy of each IGH RNA molecule tagged with 18bp random molecular identifiers and 
partial Nextera (Illumina) sequences on both ends (Nextera_A for V_Leader, 
Nextera_B for C_long) (Fig. 1). We then amplify these uniquely tagged cDNAs using 
primers specific to the partial Nextera sequences that preserve the molecular 
identifiers and add dual-indexed complete the Nextera sequences. This dual-indexed
~530bp amplicon library is at this point Illumina-sequencing-ready. We then split the 
library into three aliquots. The first and second aliquots (Tn5_A and Tn5_B) are 
tagmented with Tn5 enzyme loaded only with partial Nextera_A (Tn5_A) or 
Nextera_B (Tn5_B) oligos and PCR amplified to complete the Nextera_A (Tn5_A) or 
Nextera_B (Tn5_B) sequences, respectively (Fig. 1). The third aliquot (Uncut) is left 
unchanged and sequenced alongside the Tn5_A and Tn5_B libraries (Fig. 1). 
Illumina chemistry only sequences molecules with both complete Nextera_A and 
Nextera_B sequences at their ends (Fig. 1). Therefore, Tn5_A and Tn5_B libraries 
exclusively produce raw read pairs in which one read is anchored by the V_Leader 
(Tn5_A) or C_long (Tn5_B) primers and contains one of the molecular identifiers 
associated with the original template molecule, whereas the other read is primed 
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from the Nextera sequence introduced at a random location into the amplicon by 
Tn5. Finally, the Uncut library exclusively produces raw read pairs in which both 
reads are anchored by V_Leader or C_long primers and contain both molecular 
identifiers associated with the original template molecule (Fig. 1). For analysis, after 
quality trimming and filtering, Uncut, Tn5_A and Tn5_B read pairs containing highly 
similar molecular identifiers (Fig. S1) in their anchored reads are combined into IGH 
molecule groups. IGH molecules are then assembled from each group using 
AMPssembler, a custom k-mer based amplicon assembler that takes advantage of 
the known properties of the TMIseq protocol. Namely, the ends of the assembled 
sequences are defined by the anchored reads and there is only a single sequence to
be assembled per IGH molecule group.
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Figure 1: Schematic TMIseq Library Preparation and Data Analysis.
IGH RNA is reverse transcribed and second and third strand cDNA is generated 
using 5prime modified primers. After PCR amplification the amplicons are tagmented
using custom loaded Tn5 enzymes. 3 libraries per sample are sequenced and the 
resulting reads are grouped using molecular identifiers and assembled with a custom
algorithm (AMPssembler).
Application of TMIseq to the analysis of IGH transcript amplicons
To test the TMIseq protocol and data analysis, we created TMIseq libraries from two 
individuals (I1 and I2) from samples of PBMCs (Peripheral Blood Mononuclear Cells)
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which contain B cells. For I1, we generated TMIseq Uncut, Tn5_A, and Tn5_B 
libraries for one sample (I1 L1), sequenced those libraries on a MiSeq 2x300 run and
truncated the resulting reads to 150bp to model the shorter read length. The MiSeq 
run generated 125,200 raw reads for the I1 libraries, which yielded 120,104 quality 
trimmed reads. The trimmed read pairs were assembled by AMPssembler into 2779 
IGH molecules. For I2, we generated TMIseq Uncut, Tn5_A, and Tn5_B libraries for 
8 samples (I2 L1-L8) and sequenced those libraries on a HiSeq3000 2x150 run. The 
HiSeq run generated 15,587,484 raw reads pairs across the 8 I2 samples, which 
yielded 10,577,945 quality trimmed read pairs. These trimmed read pairs were 
assembled by AMPssembler into 115,108 IGH molecules (11,075-16,985 per 
library).
TMIseq coverage requirements
We used I2 L1 data to determine the coverage requirements to assemble IGH 
molecules and enable future optimization of raw read depth. Successful assembly 
was strongly dependent on read coverage, which itself was strongly positively 
correlated between the Uncut and Tn5_A/Tn5_B libraries (Fig. 2A, B). TMIseq 
assembly success increased from 15% for IGH molecules covered by only one 
Uncut read pair to 60-70% for reads covered by 5 or more Uncut read pairs (Fig. 
2C), with the assembly success of individual molecules being highly dependent on 
Tn5_A and Tn5_B coverage, reaching over 90% for IGH molecules covered by more
than 40 combined Tn5_A and Tn5_B read pairs (Fig. 2C).
Next, we performed rarefaction analysis to determine the ideal coverage levels 
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required for effective assembly. While subsampling of the Tn5_A and Tn5_B raw 
reads had a strong impact on the number of IGH molecules that were successfully 
assembled, subsampling of the Uncut raw reads had only minimal effect until the 
number of raw reads fell below 2-5 times the maximum number of assembled IGH 
molecules (Fig. 2D). A good trade-off between assembled IGH molecules and raw 
read coverage therefore appears to be 5 Uncut raw reads and 30-40 raw reads each
for Tn5_A and Tn5_B for every high abundance IGH molecule in the Uncut library. 
This compares highly favorably to other approaches that enable the sequencing of 
molecules exceeding the Illumina read length limit (Hong et al. 2014). Further, raw 
read requirements are likely to be lower if using a HiSeq2500, as the HiSeq3000 has
a preference for short molecules, which resulted in ~40% of Tn5_A and Tn5_B reads
to be discarded in a quality filtering step because they were too short or contained 
adapter sequences.
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Figure 2: TMIseq Subassembly Coverage Requirements.
A) Read pair coverage for IGH molecules in the I2 L1 Uncut library is shown as a 
histogram. Average Combined Tn5_A and Tn5_B read coverage at increasing Uncut
raw read coverage levels is shown as a color gradient.
B) Average assembly success at increasing I2 L1 Uncut read coverage levels is 
shown.
C) Heatmap showing the correlation of assembly success and read coverage in I2 
L1. Average Success percentage for Tn5_A and Tn5_B coverage combinations is 
shown.
D) Number of I2 L1 IGH molecules successfully assembled from increasing numbers
of subsampled Uncut raw read pairs (line colors) and combined Tn5_A and Tn5_B 
raw read pairs is plotted.
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TMIseq data quality
To assess TMIseq data quality and characteristics we analyzed IGH molecules 
assembled from the I1 L1 library. The average length of the assembled IGH 
molecules was 530bp (Fig. 3A) and trimmed Tn5_A and Tn5_B reads aligned to the 
assembled molecules in the pattern expected based on the library prep protocols 
(Fig. 3B). Of the 2779 assembled IGH molecules, 98% were identified as heavy 
chain transcript and annotated by IgBlast (Ye et al. 2013). We then compared these 
annotated IGH molecules to standard molecular-identifier based immune repertoire 
control data (I1 Control) derived from a biological replicate and produced using a 
shorter 400bp amplicon and a 2x300 run on a MiSeq (Fig. 4A).
To assess base-exchange errors we took advantage of IgD sequences which are 
thought to be expressed almost exclusively by naïve B cells. The vast majority of 
sequenced IgD sequences should therefore be not mutated. Indeed, we found that 
most IgD sequences were not mutated: 95.16% of IgD sequences in the I1 L1 
TMIseq library and 93.6% of IgD sequences in the I1 Control library showed >99% 
identity to reference ). Most importantly, the percentage of mutated IgD sequences 
was comparable between TMIseq and error-corrected control libraries
Next, we tried to assess the rates of artificial insertion and deletions of the TMIseq 
protocol, which, as it relies on computational assembly of sequences, might be prone
to generate the kinds of errors. First, we analyzed the observed CDR3 length and 
potential frame-shifts in the variable region. Lengths of the CDR3s, which is the 
result of the random recombination of V, D, and J segments and the addition of 
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quasi-random P and N nucleotides, are expected to occur in steps of three to 
maintain the reading frame of the antibody heavy chain transcript. Second, we 
analyzed indels occurring in the rest of the Variable region. Indels in the variable 
region should occur in multiples of three to result in the addition or loss of whole 
amino acids, while maintaining the reading frame of the transcripts. We found that 
the rates of out-of-frame CDR3 (Fig. 4B, C) and frame-shift events in the rest of 
Variable region (Fig. 4D) were very similar between I1 L1 TMIseq and I1 Control 
libraries. Together, this confirmed that the rate of errors generated by the TMIseq is 
equivalent to the very low rates of the error-corrected control protocol (Vollmers et al.
2013).
   
Figure 3: TMIseq Assembles 530bp IGH Molecules
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A) Length distribution of I1 L1 IGH molecules assembled using TMIseq.
B) Trimmed Tn5_A and Tn5_B reads are mapped to assembled IGH molecules 
using BLAST. Mapped read coverage across IGH transcripts is shown as 
histograms.
   
Figure 4: TMIseq Mutations Data Equivalent to Control Libraries
A) Schematic of Primer positioning for second and third strand synthesis in TMIseq 
and control Libraries. B-D) Control and TMIseq sequences are compared for CDR3 
length distribution (B), CDR3 translation frame (C), shift in frame produced by indels 
(D).
Variable and Constant region coverage by IGH amplicon and TMIseq
The increased sequencing length made possible by TMIseq enabled us to create a 
longer amplicon by priming in the Leader exon and 100bp into the Constant region. 
Priming in the Leader exon, which is not included in the final antibody protein allowed
us to read every base of the Variable region without it possibly modified by a primer. 
This enabled us to uniquely identify all V segment alleles. In contrast to the I1 
Control library, the I1 L1 TMIseq library was able to identify the V segment allele 
IGHV3-23*04 that differs from the more common IGHV3-23*01 allele by a single 
base in the first 20bp of the segment (Fig. 5A). Additionally, priming in the Leader 
exon enables us to identify mutation hot spots in the entire Variable region, including 
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potential hot spots in the first 20 bases of the IGHV3 V segments family (Figure 5B).
On the other end of the amplicon, priming 100bp into the Constant regions creates 
an amplicon that contains enough distinct base positions to not only distinguish 
isotypes like IgM and IgG, but isotype subtypes like IgG1 and IgG3. Indeed, in 
contrast to the I1 Control Library, the I1 L1 TMIseq library differentiates isotype 
subtypes including IgG1, IgG2, and IgG3 as well as IgA1 and IgA2 (Fig. 5C). While 
IgG4 and IgE which are essential for allergy research were only detected at very low 
levels in the data, this is likely due to the low sequencing depth and their naturally 
low levels in a mix of IGH transcripts.
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Figure 5: TMIseq can differentiate all V segments and Isotypes
A-B) Control and TMIseq sequences are compared for perfectly matched V segment 
usage in a scatter plot (A), and Isotype usage in a pie chart (B). C) Mutation rate 
across the entire V segment averaged across all IGH molecules using V segments of
the IGHV3 family.
Finally, to test the data for obvious recurring assembly artifacts and contaminations, 
we compared IGH molecules derived from all I1 and I2 libraries. Similar to what we 
had previously shown for standard immune repertoire data (Vollmers et al. 2013), 
IGH molecule lineages derived from I1 and I2 samples were shared at high levels 
between the samples of an individual, yet only at very low levels between individuals 
(Fig. 6), which confirmed the absence of rampant cross contamination and assembly 
artifacts.
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Figure 6: TMIseq Data Identifies Clonal IGH Lineages
Visualization of IGH molecule lineages shared between samples. IGH molecule 
lineages of each sample are plotted on the circumference of the circle, with the area 
representing abundance of the respective lineages (logarithmic) and the color 
representing isotype. IGH molecule lineages present in two time points are 
connected with lines colored according to their isotype.
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Discussion
In this study, we show that the TMIseq protocol we developed enables the 
sequencing of amplicons that exceed Illumina read length but not cluster generation 
length. With the current state of technology, this includes amplicons 450bp-800bp in 
length. We applied TMIseq to IGH amplicons creating an immune repertoire 
sequencing protocol that is unprecedented in its combination of sequencing accuracy
and coverage of Variable and Constant regions. Indeed, there currently exists no 
other protocol to accomplish this combination. Coverage of the complete variable 
region will make it possible to query all possible mutations in an antibody and adapt 
antibody repertoire sequencing for the pairing of heavy and light chains as was 
recently shown for T cells (Howie et al. 2015). Further, we have shown here that 
complete variable region coverage, paired with error-correction, enables the 
identification of highly similar but distinct V segment alleles. This distinction will be 
essential for the inferred haplotype phasing of the IG loci which was shown 
previously but hampered by the lower throughput and accuracy of the 454 sequencer
(Kidd et al. 2012). Finally, in addition to the coverage of the complete variable region,
the increase coverage of the Constant region enables the identification of isotype 
subtypes for each molecule, which is essential for the study of class-switching and 
allergies (Looney et al. 2016). The protocol we present is straightforward and cheap 
to implement by allowing for pooling strategies to minimize the use of Tn5 enzyme. 
In our hands the complete protocol, from RNA to sequencing libraries, can be 
completed in a single day. The sequencing cost per TMIseq sample is lower than 
sequencing a shorter amplicon, which would omit either Variable or Constant region 
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coverage, on a MiSeq 2x300 run using molecular identifiers for error-correction. 
While we applied the TMIseq protocol to IGH amplicons, it will be easy to adapt the 
protocol to any other amplicon. There are several amplicon based applications for 
which this might be beneficial. These applications include among others the 
sequencing of 16S RNA and cancer amplicon panels. Taken together, data quality 
and coverage requirements shown here prove that the TMIseq protocol is capable of 
sequencing full-length immune repertoires, or any other amplicon between 450bp 
and 800bp, highly accurately and at high throughput.
Methods
PBMC extraction and RNA purification
All experiments were approved by the Internal Review Board at UC Santa Cruz and 
Stanford University. For sample I1 whole Blood samples were collected from a 
healthy human adult volunteer by the UCSC Student Health Center. For sample I2, 
buffy coat were provided completely de-identified by the Stanford Blood Center. I1 
and I2 samples were processed by Ficoll-Gradient (GE-Health) to extract PBMCs. 
PBMC were lysed directly in RLT buffer and frozen at -80°C until RNA was 
extracted. RNA was extracted from 400,000 cells each using the RNeasy Mini Kit 
(Qiagen). Resulting RNA concentrations ranged from 20-50ng/ul.
TMIseq Library Preparation
10ul of RNA was used for Superscript II (Thermo) cDNA first strand synthesis using 
a primer pool specific to all exons specific to the secreted isoform of all IGH isotypes 
(IgM, IgD, IgG1-4, IgA1-2, IgE). In a 2 cycle PCR reaction 2nd and 3rd cDNA strands
were synthesized using Phusion polymerase (Thermo) and 2 modified primer pools 
complementary to the beginning of the V-Leader exons and about 100bp into CH1 
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exons of all IGH isotypes and containing molecular identifiers and partial Nextera 
Sequences. cDNA was purified and size selected twice with SPRI beads using a 
0.7:1 (Beads:Sample) ratio corresponding to a cutoff discarding DNA shorter than 
300bp. In a 30 cycle PCR reaction 3rd cDNA strands were amplified using a pair of 
primers containing complete Nextera sequences as well as Illumina i5 and i7 indexes
to index each individual sample. Samples with unique i5 and i7 indexes (i.e. each 
sample can be uniquely distinguished by either i5 or i7 index, e.g. Sample 1: i5_1, 
i7_1; Sample 2: i5_2, i7_2; etc...) are pooled and split into three aliquots. To create 
Tn5_A libraries, aliquot 1 is tagmented using Tn5 enzyme(Picelli et al. 2014) loaded 
with Nextera_A adapter and PCR amplified using a universal Nextera_B primer and 
a Nextera_A primer with a Illumina Index not yet present in the library pool and 
purified and size selected for fragments larger than 380bp using 2% EX Gels (Life). 
To create Tn5_B libraries, aliquot 2 is tagmented using Tn5 enzyme(Picelli et al. 
2014) loaded with Nextera_B adapter and PCR amplified using a universal 
Nextera_A primer and a Nextera_B primer with a Illumina Index not yet present in 
the library pool and purified and size selected for fragments larger than 380bp using 
2% EX Gels (Life). Uncut (aliquot 3), Tn5_A, and Tn5_B libraries were pooled and 
sequenced according to standard Illumina protocols on an Illumina MiSeq 2x300 run 
or HiSeq3000 2x150 run.
Control Library Preparation
Control libraries were generated as TMIseq libraries with the exceptions to the primer
pools used for 2nd and 3rd strand cDNA synthesis. The FR1 specific primer pool 
was designed to bind 1-10bp into the FR1 region, while the C specific primer pool 
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was designed to bind 20bp into the CH1 exons of all IGH isotypes. The resulting 
library with an insert size of ~400bp is sequenced on an Illumina MiSeq 2x300bp run.
Raw data processing data assembly
Raw reads in fastq format are trimmed using trimmomatic (Bolger et al. 2014), 
discarding reads pairs containing adapters. For libraries sequenced on the MiSeq 
2x300, reads were also cropped to 150bp. TMIseq data was further processed 
according to the following pipeline: First, molecular identifiers are extracted from the 
trimmed fastq files. For Uncut libraries the first 18 bases of read 1 represent 
molecular identifier 1 and the first 18 bases of read 2 represent molecular identifier 2.
For Tn5_A libraries the first 18 bases of read 2 represent molecular identifier 2. For 
Tn5_B libraries the first 18 bases of read 1 represent molecular identifier 1. Second, 
reads of the Uncut library are grouped into molecular groups if their combined 
molecular identifiers differed by less than 5 mismatches. Third, reads with highly 
similar (less than 2 mismatches) molecular identifier 1 (Tn5_B) or molecular identifier
2 (Tn5_A) to the Uncut molecular groups are added into these molecular groups. 
Third, the AMPssembler algorithm assembles IGH transcripts from each molecular 
group. The program sorts the raw reads into three categories: 1.) reads derived from 
the 5' "end" of the amplicon. 2.) reads derived from the 3' "end", and 3.) reads which 
are unachored and likely to come from some place in the middle of the molecule. 
Then the program creates a high-quality consensus of the ends of the amplicon 
using a combination of quality and abundance of each nucleotide at each position. 
Finally, the program reduces all of the reads into k-mers and extends one of the ends
until the program reaches the other end of the amplicon or the program runs out of 
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extensions. It then reports the completed molecule in fastq format. When multiple 
extensions are possible, the program always selects the extension which results in 
the highest-quality base being incorporated into the extension. Control data was 
processed as previously described (Vollmers et al. 2013). To analyze molecule 
coverage distribution in Fig. 2B we aligned the raw reads of each molecule group to 
the assembled molecule using BLAST (Altschul et al. 1990). Data was then 
converted to fasta format and annotated using IgBLAST (Ye et al. 2013) with 
germline data retrieved from IMGT (Lefranc et al. 2004). For Fig. 2C IGH molecules 
were grouped into lineages across all samples analyzed using a single linkage 
clustering approach and a 90% CDR3 similarity cut-off. For Fig. 1E reads were 
subsampled to the approximate target levels from the unprocessed fastq file pairs. 
The resulting subsampled files were then analyzed by the complete analysis 
pipeline. Further downstream analysis and visualization was done using 
Python/Matplotlib (Hunter 2007).
Data Access
The AMPssembler script used in the analysis of the data is available at Github at 
https://github.com/chkcole/AMPssembler. All other scripts are available upon 
request.
Raw data was uploaded to the SRA under Bioproject ID PRJNA291102 (I1 data are 
identified by anonymized ID SHC1-3-1, I2 data are identified by anonymized ID 
BB7)
Aim 2: Heavy and Light Chain Pairing
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Abstract
RNA-seq is a powerful technique to investigate and quantify entire transcriptomes. 
Recent advances in the field have made it possible to explore the transcriptomes of 
single cells. However, most widely used RNA-seq protocols fail to provide crucial 
information regarding transcription start sites. Here we present a protocol, Tn5Prime,
that takes advantage of the Tn5 transposase based Smartseq2 protocol to create 
RNA-seq libraries that capture the 5’ end of transcripts. The Tn5Prime method 
dramatically streamlines the 5’ capture process and is both cost effective and 
reliable. By applying Tn5Prime to bulk RNA and single cell samples we were able to 
define transcription start sites as well as quantify transcriptomes at high accuracy 
and reproducibility. Additionally, similar to 3’ end based high-throughput methods like
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Drop-Seq and 10X Genomics Chromium, the 5’ capture Tn5Prime method allows the
introduction of cellular identifiers during reverse transcription, simplifying the analysis
of large numbers of single cells. In contrast to 3’ end based methods, Tn5Prime also 
enables the assembly of the variable 5’ ends of antibody sequences present in single
B-cell data. Therefore, Tn5Prime presents a robust tool for both basic and applied 
research into the adaptive immune system and beyond. 
Introduction
As the cost of RNA-sequencing has decreased, it has become the gold 
standard in interrogating complete transcriptomes from bulk samples and single 
cells. RNA-seq is a powerful tool to determine gene expression profiles and identify 
transcript features like splice-sites. However, standard approaches lose sequencing 
coverage towards the very end of transcripts. This reduced coverage means that we 
cannot confidently define the 5’ ends of mRNA transcripts which contain crucial 
information on transcription initiation start sites (TSSs) and 5’ untranslated regions 
(5’UTRs). Analyzing TSSs can help infer the active promoter landscape, which may 
vary from tissue to tissue and cell to cell. Analyzing 5’UTRs, which may contain 
regulatory elements and structural variations can help infer mRNA stability, 
localization, and translational efficiency. Identifying such features can help elucidate 
our understanding of the molecular mechanisms that regulate gene expression. 
The loss of sequencing coverage towards the 5’ end of transcripts is often 
attributed to how sequencing libraries are constructed. For example, the widely used 
Smartseq2 RNA-seq protocol, a powerful tool in deciphering the complexity of single 
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cell heterogeneity(Picelli, Faridani, et al. 2014; Treutlein et al. 2014; Darmanis et al. 
2015), features reduced sequencing coverage towards transcript ends. This lost 
information is a result of cDNA fragmentation using Tn5 transposase. Several 
technologies have tried to compensate for the lack of coverage by specifically 
targeting the 5’ ends of transcripts. The most notable methods include cap analysis 
of gene expression (CAGE), NanoCAGE, and single-cell tagged reverse transcription
sequencing (STRT)(Islam et al. 2011, 2014; Salimullah et al. 2011; Shiraki et al. 
2003). CAGE uses a 5’ trapping technique to enrich for the 5’-capped regions by 
reverse transcription (Shiraki et al. 2003). This technique is extremely labor intensive
and involves large amounts of input RNA. The NanoCAGE and STRT methods 
target transcripts using random or polyA priming and a template-switch oligo 
technique to generate cDNA (Islam et al. 2011; Salimullah et al. 2011). While 
NanoCAGE can analyze samples as low as a few nanograms of RNA, and STRT 
can be used to analyze single cells, they both require long and labor-intensive 
workflows including fragmentation, ligation, or enrichment steps. Therefore, none of 
the current 5’ end specific protocols are capable of efficiently and cost-effectively 
processing hundreds to thousands of single cells necessary to understand 
heterogeneity within complex mixtures of cells present in, for example, the adaptive 
immune system or cancer. 
Furthermore, new droplet based high-throughput single cell RNAseq 
approaches like Drop-Seq and 10X Genomics Chromium platform can process 
thousands of cells but can only analyze the 3’end of transcripts due to integrating a 
sequencing priming site into the oligodT primer used for reverse transcription. By 
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losing information of the 5’ end almost entirely, these approaches are not capable of 
comprehensively analyzing cells of the adaptive immune cells which express 
antibody or T cell receptor transcripts featuring unique V(D)J rearrangement 
sequence information on their 5’ end.
To overcome this lack of high-throughput single cell 5’ capture methods, we 
chose to modify the Smartseq2 library preparation protocol which is relatively cost-
effective and simple with features of STRT which captures 5’ ends effectively. Here 
we describe a robust and easily implemented method called Tn5Prime that performs 
genome-wide profiling across the 5’ end of mRNA transcripts in both bulk and single 
cell samples. The protocol is based on integrating one sequencing priming site into 
the template switch oligo used for reverse transcription and subsequently tagmenting
the resulting amplified cDNA by Tn5 enzyme loaded with an adapter carrying the 
other sequencing priming site. This combination allows for the construction of 
directional RNAseq libraries with one read anchored to the 5’ end of transcripts 
without the need for separate fragmentation, ligation, and, most importantly, 
enrichment steps. Additionally, by incorporating cellular identifiers into the template 
switch oligo makes it conducive for pooling samples after reverse transcription, 
thereby increasing throughput and reducing cost. Finally, data produced by this novel
approach allows for the identification of transcription start sites, the quantification of 
transcripts, and the assembly of antibody heavy and light chain sequences from 
single B cells at low sequencing depth.  
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Results
Construction of Tn5Prime libraries
Tn5Prime libraries can be constructed from either purified total RNA or single 
cells sorted by FACS into multiwell PCR plates. Tn5Prime libraries create a 
directional paired-end Illumina RNAseq library with read 1 anchored to the 5’ end of 
transcripts. Directionality and read 1 anchoring is achieved through the use of our 
modified template-switch oligo and custom Tn5 enzyme. After the addition of reverse
transcriptase to total RNA or cell lysate, first-strand synthesis occurs using a 
modified oligo-dT and a template-switch oligo (TSO) containing a partial Nextera A 
adapter sequence and, optionally, a cellular index sequence (Table S1, Fig. 1A). 
During reverse transcription, the oligo-dT serves as a primer at the 3’ polyA tail of 
mRNA transcripts, while the sequence of the partial Nextera A template-switch oligo 
is attached to the 3’ end of the synthesized cDNA corresponding to the 5’ end of 
transcript sequences. After reverse transcription, samples with non-overlapping 
cellular indexes can be pooled. The cDNA product is then amplified using a complete
Nextera A primer and a primer complementary to the modified 5’ end of the oligo-dT. 
After amplification, the cDNA product will contain a complete Nextera A adapter 
including Illumina indexes. At this point, samples that contain the non-overlapping 
Illumina indexes can be pooled. By pooling after reverse transcription and PCR 
amplification, we can dramatically reduce the workflow complexity and reagent 
usage.
Next, Tn5 transposase, loaded only with a partial Nextera B adapters, 
fragments the cDNA and attaches the partial Nextera B adapters to the cDNA in a 
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single reaction. The cDNA fragments are then amplified using a universal A primer 
and a Nextera B primer that primes off the partial Nextera B adapter sequences 
attached by the Tn5 enzyme. The final product is compatible with the Illumina 
platform by containing the complete Nextera A and Nextera B adapters. Libraries are
then ready to be size selected and quantified prior to sequencing. At this point, no 
enrichment step is necessary, as only molecules containing both Nextera A and B 
adapters will be targeted for sequencing. Since only the TSOs associated with the 5’ 
end of transcripts contain Nextera A adapters, read 1 of all read pairs in the 
sequencing reaction begins at these 5’ ends and extends into the transcript body, 
thereby identifying transcription start site and directionality (Fig. 1A-C). Read 2 is 
distributed throughout the gene body, as each location represents the random 
insertion of Nextera B adapters by Tn5 and library size selection (Fig. 1B,C).
Creating and analyzing Tn5Prime data of GM12878 cell line RNA   
 
To evaluate whether our Tn5Prime protocol consistently identifies the 5’ end 
of the transcript we first performed low coverage RNAseq of total RNA of GM12878 
cultured lymphoblast cells. We performed a side-by-side comparison of our protocol 
with the standard Smartseq2 protocol using the same starting material. Using the 
HiSeq2500 platform (Illumina) we obtained 570805 and 453761 raw read pairs for 
two replicate Tn5Prime libraries. We next obtained 1094530 raw read pairs from a 
Smartseq2 library. Adapter sequences and low quality reads were removed using 
Trimmomatic (Bolger, Lohse, and Usadel 2014). In the Tn5Prime replicates, 92.51% 
and 92.62% of the trimmed and filtered reads mapped uniquely to the human 
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genome using the STAR alignment tool (Dobin et al. 2013), surpassing the standard 
Smartseq2 protocol at 88.50%. The uniquely aligned reads from the TN5Prime 
replicates collectively had a redundancy of 1.34. This high unique alignment 
percentage indicates that our Tn5Prime protocol produces libraries of high 
complexity.
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Fig. 1 Tn5Prime Library construction and 5’ capture
A.) Schematic of the Tn5Prime library construction. No enrichment steps are required to 
generate a library that captures the 5’ end of transcripts. B.) Read alignment plots comparing 
5’ end capture by Tn5Prime to random fragmentation by Smartseq2 using lymphoblast cell 
line GM12878. A total input of 50 ng of RNA was used. Individual alignments for the first 
(Read1, blue) and second (Read2, red) read of each read pair are shown. Read1 density is 
shown for both library types as a histogram (blue). Gene models are shown on the top panel 
(Color indicates transcriptional direction.)
Detecting Transcription Start Sites using Tn5Prime
We analyzed the read distribution across transcripts both visually and systematically 
to determine the 5’ specificity of our protocol. Visual inspection found that while 
Smartseq2 reads are distributed across the entire body of genes, Tn5Prime reads 
follow two distinct patterns: First, the start of the read 1 is anchored to the 
transcription start site. Second, the start of read 2 is variable and likely dependent on
size selection during library preparation (Fig. 1B). Next, systematic analysis was 
based on mapping the start of read 1 to identify putative Transcription Start Sites 
(TSSs). To test our ability to identify TSSs, we compared our Tn5Prime data to the 
Gencode genome annotation and CAGE data which was generated from the same 
GM12878 cell line from the ENCODE project. We identified putative TSSs by calling 
peaks enriched from the start of read 1 in our Tn5Prime data (see Methods). 89.7% 
of the 17853 peaks  fell within TSSs (0-25 bp upstream) with the vast majority of 
them falling near promoter regions (26bp-1000bp upstream) or 5’UTRs (Fig. 2A). 
Next, we subsampled the CAGE data to levels similar to the Tn5Prime data and 
called peaks in the same manner. We found that 14107 of 17853 Tn5Prime peaks 
(73%) fell within 25bp to the nearest of 27526 CAGE peaks, indicating high 
concordance between the two approaches (Fig. 2B). Tn5Prime peaks (3,746) that 
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were not within 25bp of a CAGE peak contained far less sequencing reads on 
average than those within 25bp of a CAGE peak. These results indicate that these 
transcripts might be expressed at lower levels and show more variance between the 
Tn5Prime and CAGE datasets (Fig. 2B). Ultimately, this suggests that our Tn5Prime 
protocol is equivalent to the gold standard CAGE technique in targeting transcription 
start sites.
Fig. 2 Tn5Prime peaks are highly concordant with GENCODE annotation and CAGE 
peaks 
A) Tn5Prime peaks identified in lymphoblast cell line GM12878 using 50 ng of input RNA 
were matched to features determined by Gencode annotation. Features are shown as a pie 
chart. B) Tn5Prime peaks generated from GM12878 were matched to CAGE peaks also 
generated from GM12878. The green bar on top indicates the peaks within 25 bp and the 
yellow bar indicates all other peaks. Peaks in each were rank sorted according to their read 
coverage and shown as a histogram. 
Quantifying the Transcriptome using Tn5Prime
After validating the ability of Tn5Prime to detect transcription start sites, we next 
wanted to examine whether it is capable of transcript quantification. To determine 
whether our Tn5Prime method is quantitative we compared GM12878 data 
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generated from four different protocols: Tn5Prime, Smartseq2 data generated by our 
lab, as well as CAGE and RNA-seq data produced by the ENCODE project (Fig. 3). 
We used the Tn5Prime data mentioned in the previous section and generated the 
Smartseq2 data on the same Cell line as described by (Picelli, Faridani, et al. 2014). 
We performed replicates using the Tn5Prime protocols to define overall 
reproducibility and accuracy. Based upon our results, transcript quantification by 
Tn5Prime replicates showed extremely high correlation with a Pearson correlation 
coefficient of r=0.97 (95% C.I. 0.97-0.97). Quantification by Tn5Prime also correlated
very well with Smartseq2 with a Pearson r of 0.87 (95% C.I. 0.86-0.87). Tn5Prime 
and Smartseq2 data were comparable with ENCODE RNA-seq and CAGE data (Fig.
3), indicating that the Tn5Prime protocol is equivalent to the conventional Smartseq2 
method in measuring transcript abundance. Together, these data show that 
Tn5Prime can accurately identify transcription start sites and quantitatively measure 
transcript abundance.
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Fig 3. Tn5Prime quantifies transcriptomes accurately and reproducibly.
Pairwise correlations of transcript levels between Tn5Prime, Smartseq2, ENCODE CAGE 
and ENCODE RNAseq experiments using GM12878 cell line are shown as scatter plots. A 
total of 50 ng of input RNA was used. Each transcript is shown as a black dot with an opacity
of 5%. Distribution of transcript levels is shown on the outside of the plots in grey 
histograms.
Transcript quantification and transcription start site localization in single B 
cells.
As the Tn5Prime protocol is based on the same cDNA amplification strategy as the 
Smartseq2 protocol, we expected it capable of generating sequencing libraries from 
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single cells. Indeed, we successfully generated single cell libraries using the 
Tn5Prime protocol from primary murine B-lymphocytes (B2 cells; IgM+B220+CD5-
CD11b-)(n=12) isolated from the peritoneal cavity. We generated between 17,534-
93,429 2x300 bp read pairs per cell using the Illumina MiSeq of which 62% passed 
quality filtering. Of the filtered reads, an average of 91.48% uniquely mapped to the 
mouse genome. The high alignment percentage indicates we are able to generate 
high quality libraries from single cells using our Tn5Prime. Despite the very low total 
number of read pairs we collected, we still detected 339 expressed genes per cell on
average. Although these numbers may seem low, they are in line with previously 
published data on single B cell RNAseq (Zheng et al. 2017; Jaitin et al. 2014; 
Gierahn et al. 2017).Among the genes expressed in many of the single cells were 
genes corresponding to B cell function, including  CD19, CD79a and components of 
the MHC complexes (Fig. S1). These data indicate that we can efficiently identify cell
type specific genes.
Analysis of 192 Single CD27high CD38high Human B Cells
After successfully testing our Tn5Prime method on single mouse B cells, we next 
wanted to develop a multiplex approach capable of evaluating hundreds of human 
single cells. To this end, we FACS sorted 192 single B cells into individual wells of 96
well plates using the canonical surface molecules CD19, CD27 and CD38 to sub-
select the plasmablast subpopulation (Fig. S2). Plasmablasts are one of the most 
widely studied B cell populations and are frequently monitored after vaccination or 
infections by flow cytometry. The plasmablast cell compartment is defined by high 
levels of surface markers CD27 and CD38, but separation from memory B cells 
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which also express these markers, albeit at lower levels, can be challenging. 
Therefore, analyzing these cell types at the single cell level should help further 
delineate these populations. 
We developed a multiplex strategy by inserting cellular indexes into the 
template switch oligo which allows the user to pool samples after reverse 
transcription. This streamlines our method and increases our throughput by 
decreasing the PCR and Tn5 reactions required. Using our multiplexing strategy we 
generated Tn5 libraries for 192 single B cells using 192 RT reactions, 24 PCR 
reactions and 24 Tn5 reactions. Although this was not performed, library pools 
carrying distinct Illumina sample indexes could have been further pooled following 
PCR to reduce the numbers of Tn5 reactions from 24 to 2.  
We generated 194,553,648 150 bp paired end reads total. To determine gene
expression for each cell, reads were assigned to one of 192 single cells based on its 
Illumina index reads and by comparing the sequence of the first 8 bases of read 1 to 
the cellular index sequences.  91% of the 194,553,648 150bp paired end reads were
successfully assigned to one of the 192 single B cells. 90.75% of cell-assigned reads
were successfully aligned to the human genome using STAR with a median of 
74.59% percent of cell-assigned reads being uniquely assigned to an annotated 
gene. Each cell expressed a median of 534 genes. Of the 58234 annotated genes in 
GENCODE, 5414 genes had at least one read per cell on average. The median 
redundancy for each cell is 13.92 which means that, on average, each uniquely 
aligned cDNA fragment was sequenced 13.92 times. This indicates that the libraries 
were sequenced exhaustively. 
49
Detecting Transcription Start Sites in single CD27high CD38high B cells using 
Tn5Prime
To determine if transcription start site specificity is maintained within the single cell 
data, read 1 start distribution was compared to annotated transcription start sites and
Encode CAGE data. By calling peaks, we found that our single cell results were able 
to maintain transcription start site specificity, with peaks predominantly falling within 
the annotated transcription start sites (Fig. 4A-B). In addition to the transcription start
site, the directionality of transcription can be inferred due to our custom template 
switch oligo incorporating a forward-read priming site to the 5’ region of the transcript
which is an advantage over many other single cell RNAseq protocol (Fig. 4C,D).
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Fig 4. Transcription start sites are detected in single CD27high CD38high B cells
A) CD27high CD38high Tn5Prime peaks were matched to features in the Gencode annotation 
and the feature they matched are shown as a pie chart. TSS = on or less than 25bp behind the 
start of an annotated GENCODE gene, 5’UTR = inside 5’ prime untranslated region, 
Promoter = between 26 and 1000bp behind start of annotated gene. B) Tn5 peaks were 
categorized into two groups. One group contains all peaks within 25bp of a peak identified in 
the complete RIKEN CAGE peak Human peak database and the other group contains all 
other peaks. These peaks were sorted by the number of cells associated with that peak in the 
CD27high CD28high B cell data set and displayed in figure 5a. The yellow bar indicates the 
peaks within 25bp and the green bar indicates all other peaks. C,D) Genome Browser view of
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reads of several cells aligned to Actb (C) and LTB (D) genes. In addition to TSS information,
read alignments also show differential isoform usage between cells.  
Detecting Subpopulations within CD27high CD38high B cells using Tn5Prime
Since separating memory B cells and plasmablasts by FACS based on surface 
markers can be challenging, especially when the adaptive immune system is not 
perturbed, we wanted to see whether we could do so post-sorting using their gene 
expression profiles. Cells outside more than three median absolute deviations from 
the median for percent alignment, Mitochondrial transcript percentage, or number of 
detected genes were marked as outliers and eliminated prior to normalization of 
transcript counts (Fig. S3). After normalizing raw gene expression counts and 
removing non-recombined and therefore non-applicable antibody gene segments 
from the annotation (Lun, Bach, and Marioni 2016), we clustered the remaining 159 
sorted B cells using t-SNE dimensionality reduction. The clusters were robust when 
the data was subsampled to 100,000 reads per cell (Fig. S4). We then identified 
genes that showed significant differences between the two clusters. We detected 
411 genes with significant changes including J-chain, LTB, XBP-1, HSPA5, MZB1, 
as well as HLA-DRA, HLA-DRB5, and HLA-DPB1 (Table S2). J-chain was 
upregulated in cluster 2 and is involved in antibody secretion of IgM and IgA 
(Lamson and Koshland 1984) (Fig. 5). We also found XBP-1, MZB1 and HSPA5 
were upregulated within cluster 2 and are known targets of BLIMP-1 which is 
essential in plasmablast differentiation (Fig. S5) (Minnich et al. 2016). LTB  was 
downregulated in cluster 2 and has been shown to be downregulated upon B cell 
activation (Zhu et al. 2004) (Fig. 5). HLA-DRA, HLA-DRB5, and HLA-DPB1 which 
encode for the alpha and beta chains of the MHC II complex were also 
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downregulated in cluster 2,  indicating less MHC II presentation to T cells which is 
indicative of plasma cells and plasmablasts (Calame, Lin, and Tunyaplin 2003). 
Together, this suggests that cluster 2 does represent activated plasmablasts which 
are known to secrete more antibody and display less MHC II complex than the 
memory B cells in cluster 1.
Figure 5. Clustering of CD27high CD38high B cells
159 B cells were divided into two populations by t-SNE dimensionality reduction 
(Maaten et al. 2008). In the three subplots, cells are colored based on their 
expression of example genes that were significantly differentially expressed between
the two populations as determined by a multiple hypothesis testing corrected Mann-
Whitney U tests. The cells inside the boxed area belong to cluster 2 and all other 
cells belong to cluster 1.
Assembly of antibody heavy and light chain sequences from single B cell 
Tn5Prime data
Ideally, we would not only want to identify plasmablasts based on their gene 
expression profile, but also determine the sequences of the antibodies they express. 
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Sequencing antibodies has been a long-standing challenge in B cell biology and 
antibody engineering because it requires the identification of unique pairs of 
rearranged antibody heavy and light chains for each cell. Current techniques rely 
either on the targeted amplification and sequencing of antibody heavy and light chain
genes (Wrammert et al. 2008) in single cells or on the assembly of their sequences 
from non-targeted RNA-seq data (Canzar et al. 2017). In contrast to 3’ end based 
Drop-Seq and 10X Genomics data, 5’ based Tn5Prime could potentially provide this 
antibody sequence information in addition to genome wide expression profiling, 
because the 5’ region contains the unique V(D)J rearrangement of heavy and light 
chain transcripts. 
To determine if our Tn5Prime protocol could be used for assembling antibody
heavy and light chain sequences, we assembled whole transcriptomes using 
SPAdes (Bankevich et al. 2012). IgBLAST (Ye et al. 2013) was used to identify 
transcripts containing V, D, and J gene segments rearranged in a productive 
manner. These transcripts were aligned on to Constant gene segments to identify 
isotype. The list of putative antibodies was then filtered for obvious cross-
contamination and mis-assemblies. In this way, we effectively determined heavy and 
light chain sequences and identify their unique pairings within single B cells (Fig. 6A).
Of the 192 B-cells we analyzed, we were able to assemble one heavy chain and one 
light chain to 117 B-cells. Of these 117 B-cells 46 cells had a Lambda light chain and
71 cells had a Kappa light chain. Five additional cells had one heavy chain and two 
light chains, 35 cells had no heavy chains but at least one light chain, and 35 cells 
had no heavy chains and no light chains. To determine the sequencing depth 
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requirement for successful heavy and light chain assembly, subsampling was 
performed on the reads and the assembly and pairing analysis redone (Fig. S6). We 
found 100,000 reads per cell was sufficient to assemble one heavy and one light 
chains for 91 of 117 B cells with successfully assembled chain pairs without 
subsampling. 
101 and of the 117 cells with paired heavy and light chains also passed all other 
quality filters and were clustered by t-SNE into the putative plasmablast and memory 
B cell clusters. This combination of single cell identity and paired antibody 
sequences allowed us to perform detailed analysis of differences in antibody usage 
and characteristics between those two populations. 
First, the putative plasmablast population featured less IgM antibodies than the 
memory B cell population (19% IgM in plasmablasts vs 53% in memory B cells). 
Second, using IgBlast (Ye et al. 2013), we found that both heavy (Fig. 6B) and light 
chain sequences showed significantly higher levels of somatic hypermutation in 
plasmablasts than memory B cells (Heavy chain: median 8.0% vs 3.8% somatic 
hypermutation, two-sided Monte Carlo permutation test p-value=0.0081; Light chain: 
median 4.9% vs 2.7% somatic hypermutation, two-sided Monte Carlo permutation 
test p-value=0.0117). Third, by counting and normalizing sequencing reads 
originating from antibody transcripts, we could determine and compare heavy and 
light chain expression in these two populations. Generally, light chains were 
expressed about 3-fold higher than heavy chains (Fig. 6C) with no significant 
difference between plasmablasts and memory B cells (two-sided Monte Carlo 
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permutation test p-value=0.533). However, the percentage of all aligned sequencing 
reads that originated from antibody transcripts showed dramatic differences between
plasmablasts and memory B cells. The median percentage of reads that originated 
from antibody transcripts was 23.5% in plasmablasts and only 2.2% in memory B 
cells (Fig. 6D) (Monte Carlo Permutation test two-sided p-value=0). In one 
plasmablast over 60% of all aligned sequencing reads originated from antibody 
transcripts indicating just how much of the plasmablast transcriptome can be 
dedicated to the production and secretion of antibodies. In summary, our analysis of 
antibody usage and characteristics showed that plasmablasts express more mutated
and class-switched antibodies at much higher levels than memory B cells.
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 Figure 6. Assembling Antibody transcripts from Tn5Prime data
Antibody transcripts were assembled by generating complete assembled transcriptomes for 
each cell with SPADES and then using IGBLAST to search for transcripts with antibody 
features. Antibody transcripts for each cell were filtered for mis-assemblies and mis-
annotations. Cells were sorted by the abundance of heavy chain transcripts in their Tn5Prime 
data and V(,D,) and J segment information for their heavy and light chains are shown in the 
schematic in the center. The putative cell type determined by clustering with t-SNE is 
indicated on the left. Yellow: plasmablasts, Green: Memory B cells. 
B-D) Antibody usage and characteristics were compared between plasmablasts and memory 
B cells. Somatic Hypermutation rates (B), light to heavy chain expression ratios (C) and the 
percentage of all aligned sequencing reads that originated from antibody transcripts (D) were 
compared using dotplots. Yellow: plasmablasts, Green: Memory B cells. Medians are shown 
as red lines. All p-values are calculated using two-sided Monte Carlo permutation test with 
10000 permutations.
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Discussion
Here we present a novel method for the genome-wide identification of transcription 
start sites in bulk samples and single cells. The method combines aspects of 
Smartseq2 and STRT. By modifying template-switch oligos used during reverse 
transcription to carry one sequencing adapter and loading the other sequencing 
adapter on the Tn5 enzyme used for cDNA fragmentation we anchor the sequence 
priming sites for read 1 of an Illumina read pair to the 5’ end of transcripts without the
need for fragmentation, ligation, and enrichment steps. The resulting workflow is 
easy to implement and capable of generating hundreds of libraries within a day. An 
important feature of our Tn5Prime method is the option to integrate cellular indexes 
during reverse transcription and Illumina sample indexes during PCR before Tn5 
tagmentation. This allows the pooling of samples early in the workflow and thereby 
reduces experiment complexity and reagent costs. 
We validated the Tn5Prime protocol on both bulk RNA and single cells. First, 
using 5ng of total RNA from the GM12878 cell line, we yielded similar results as the 
ENCODE CAGE data with respect to the identification of transcripts start sites. 
However, the CAGE protocol used by the ENCODE consortium used several order 
of magnitude more RNA. As the Smartseq2 protocol is already widely used, we 
expect that the Tn5Prime assay with its similar workflow and low RNA input has the 
potential to become a valuable tool for transcriptome annotation and quantification in 
the RNA-seq toolbox. 
In addition to the analysis of bulk samples, we show that our Tn5Prime 
method can be utilized for interrogating single cells, both human and mouse.  The 
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TSO-based multiplexing approach we implemented makes it possible to efficiently 
analyze thousands of cells, thereby increasing the throughput of plate based 
RNAseq library protocols in a manner that is straightforward and economical.
In contrast to other droplet or microwell based protocols, which interrogate 
only the 3’ ends of transcripts, the Tn5Prime protocols interrogates the 5’ ends of 
transcripts, thereby capturing the unique sequence information of adaptive immune 
system receptors expressed on B and T cells. These receptors are often hard to 
assemble due to their unique genomic rearrangement. Our data shows that by 
limiting sequencing reads to the 5’ end of transcripts we can analyze both 
transcriptomes as well as paired antibody heavy and light sequences with the low 
sequencing coverage of ~100,000 reads per cell, thereby enabling the analysis of 
thousands of B cells in a single sequencing run. This approach should, without any 
modification, also be applicable to T cells to map rearrangement of the T cell 
receptors. This can provide novel insights into the composition of B and T cell 
malignancies as well as the state and composition of the adaptive immune system 
with regards to solid tumors. 
To highlight the power of our approach we isolated 192 single human B cells 
from Peripheral Blood Mononuclear Cells(PBMCs) using canonical plasmablast 
markers. Not only were we able to assemble paired antibody transcripts, but we 
succeeded in clustering the cells into two populations based on their gene 
expression profiles. The genes differentially expressed between those clustered 
suggested their putative cell types. Cells in the putative plasmablast cluster 
expressed more XBP-1 (X-box binding protein 1), J-chain, HSPA5, and MZB1 
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(Marginal Zone B1), which are all involved in either B cell activation or antibody 
production and secretion. Consistent with less antigen presentation, cells in the 
putative plasmablast cluster also expressed less MHC II transcripts including HLA-
DRA, HLA-DRB5, and HLA-DPB1. Finally, MS4A1 (CD20) is also expressed less in 
the cells of the putative plasmablast cluster and is known to be downregulated in 
activated B cells. Overall, this clearly established that we could distinguish activated, 
antibody secreting plasmablasts from resting, antigen presenting memory B-cells; 
cell-types which are difficult to distinguish using conventional FACS analysis.
In addition to cell-types, we showed that Tn5Prime can be used to determine 
individual B cells’ paired antibody sequences. Together, these data allowed us to 
compare antibody usage in plasmablasts and memory B cells, showing that 
plasmablast expressed higher levels of more mutated and class-switched antibodies.
In addition to providing functional insight into cell populations, this information will 
make it possible to make informed decisions as to which antibody sequences could 
be further cloned and tested functionally for clinical, diagnostic, and research 
applications.
In summary, Tn5Prime is an RNAseq library construction protocol with a 
streamlined workflow that surpasses the economy and throughput of other plate-
based protocols. While not reaching the throughput of droplet- and microwell-based 
protocols, it generates high quality data that enables the identification of transcription
start sites and could be useful for analyzing 5’ UTR features or help improve 
incomplete genome annotations. Finally, Tn5Prime presents the currently highest 
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throughput mechanism to comprehensively analyze the individual cells of the 
adaptive immune system by determining both paired adaptive immune receptor 
sequences and gene expression profiles. 
Methods
Cell purification, RNA isolation and sorting
GM12878: RNA from 500,000 GM12878 cells was extracted using the RNeasy kit 
(Qiagen) according to manufacturer’s instructions. 
Murine B2 cells: Mice were maintained in the University of California, Santa Cruz 
(UCSC) vivarium according to Institutional Animal Care and Use Committee 
(IACUC)-approved protocols. Single murine Ter119-CD3-CD4-CD8-B220+ 
IgM+CD11b- CD5- B2 cells were isolated from wild-type C57Bl/6 mice by peritoneal 
lavage and incubated with fluorescently-labeled antibodies prior to sorting. The 
following antibodies were used to stain B-cells: Ter119, CD3 (Biolegend; 145-2C11), 
CD4 (Biolegend; GK1.5), CD8a (Biolegend; 53-6.7), B220 (Biolegend; RA3-6B2), 
IgM (Biolegend; RMM-1), CD5 (Biolegend; 53-7.3), and CD11b (Biolegend; M1/70). 
Cells were analyzed and sorted using a FACS Aria II (BD), as described (Ugarte et 
al. 2015; Smith-Berdan et al. 2015; Beaudin, Boyer, and Forsberg 2014). Human B 
cells: Primary human cells were collected from the blood of a fully consented healthy 
adult in a study approved by the Institutional Review Board (IRB) at UCSC. Single 
human B cells were isolated from PBMC using negative selection using RosetteSep 
(StemCell). The resulting B cells were sorted for CD19+ CD27high and CD38high.The 
following antibodies were used for staining B cells: CD19 (BD Pharmingen; HIB19), 
CD27 (Biolegend; 0323), and CD38 (Biolegend; HB-7). Cells were sorted using 
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FACS Aria II (BD) and analyzed using FlowJo v10.2 (FlowJo, TreeStar Software, 
Ashland, OR).
Both murine and human single cells were sorted into 96 well plates and directly 
placed into 4ul of Lysis Buffer - 0.1% Triton X-100, 0.2ul of SuperaseIn (Thermo), 1ul
of oligodT primer (IDT), 1ul of dNTP (10mM each)(NEB) - and frozen at -80°C. 
RNA-seq library construction and sequencing
4ul of RNA or Single Cell Lysate was reverse transcribed using Smartscribe Reverse
Transcriptase (Clontech) in a 10ul reaction including either a Smartseq2 TSO 
(Smartseq2 libraries) or a Nextera A TSO (Tn5Prime libraries) according to 
manufacturer’s instructions at 42°C. The resulting cDNA was treated with 1 ul of 1:10
dilutions of RNAse A (Thermo) and Lambda Exonuclease (NEB) for 30min at 37°C. 
The treated cDNA was amplified with KAPA Hifi Readymix 2x (KAPA) using the 
ISPCR primer and a Nextera A Index primer (Tn5Prime only). The resulting PCR 
product was treated with Tn5 enzyme (Picelli, Björklund, et al. 2014) loaded with 
either Tn5ME-A/R and Tn5ME-B/R (Smartseq2) or Tn5ME-B/R adapters only 
(Tn5Prime).
The Tn5 treated PCR product was then size selected using a E-gel 2% EX (Thermo) 
to a size range of 400-1000bp. GM12878 RNA Smartseq2 and Tn5Prime libraries 
were sequenced on an Illumina HiSeq2500 2x150 run, mouse B2 cell Tn5Prime 
libraries were sequenced on a Illumina MiSeq 2x300 run, and human B cell 
Tn5Prime libraries were sequenced on two Illumina HiSeq3000 runs. 
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Sequencing alignment and analysis
Smartseq2, Tn5Prime, ENCODE CAGE (GEO accession GSM849368; produced by 
the lab of Piero Carnici at RIKEN), and ENCODE RNAseq (GEO accession 
GSM958742; produced by the lab of Barbara Wold at Caltech) (ENCODE Project 
Consortium 2012) GM12878 data as well as Tn5Prime B2 data were trimmed of 
adapters low quality bases using trimmomatic (v0.33) (Bolger, Lohse, and Usadel 
2014) and a quality cutoff of Q15. Trimming of the 192 human B cell data was 
performed by Cutadapt[Cutadapt](32), filtering out all paired reads where one or 
more read had a post-trimming length of less than 25 bp. 
Trimmed reads derived from the GM cell line and single B cells were aligned to the 
human genome (GRCh38) annotated with Ensembl GRCh38.78 GTF release using 
STAR (v2.4) (Dobin et al. 2013). Trimmed reads derived from the B2 cells were 
aligned to the mouse genome (GRCm38) annotated with Ensembl GRCm38.80 GTF 
release using STAR (v2.4). Expression levels were quantified using featureCounts 
(v1.4.6-p1)] (Liao, Smyth, and Shi 2014) and normalized by total read number 
resulting in RPM (Reads Per Million).
Peaks for CAGE and Tn5Prime data were called by counting the number of unique 
fragments which began their forward read alignments (R1 for Tn5Prime) at each 
position within each chromosome and for each orientation (positive or negative). A 
peak was called at a position and orientation if at least five alignments begin at that 
position, the position one nucleotide downstream has fewer alignments beginning at 
that position, and the position one nucleotide upstream has fewer alignments 
63
beginning at that position. For the single cell data, peaks were filtered out unless 
they appeared in more than one cell. The distance between the TN5 peaks and the 
nearest CAGE peak was called by inserting the nucleotide coordinates of the CAGE 
peaks into kd-trees and then performing a nearest neighbor search on them using 
the TN5 peak coordinates. Each chromosome and orientation had its own kd-tree.
Antibody Assembly
After assignment, reads were assembled into transcriptomes using rnaSPAdes 
(Bankevich et al. 2012) with the single-cell parameters. Putative immunoglobulin 
transcripts are detected and annotated by running IGBLAST (Ye et al. 2013) against 
the assembled transcriptome using Human V,D and J segments from the IMGT 
database (Lefranc et al. 2004). Isotypes are assigned to putative IG transcripts by 
aligning constant regions to the transcripts with BWA-MEM[BWA-MEM paper] (Li 
2013). 
Antibody transcripts were filtered with the following process:
1. A table is generated from the SPADES/IGBLAST/BWA pipeline listing each 
putative IG transcript for each cell in which each row represents one assembled 
antibody transcript and contains information indicating which cell it came from, the 
overall abundance(as determined by BWA) within the cell,the CDR3 sequence and 
the type(IGH,IGK,IGL) as well as the inferred segments used during VDJ 
recombination.
2. The transcripts are clustered by CDR3 sequencing similarity using a single-linkage
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clustering algorithm Based on the Levenshtein distance where two clusters of 
transcripts are merged when at least one transcript CDR3 has a Levenshtein 
distance of 2 or less with the CDR3 of any transcript in another cluster.
3. Transcripts belonging to the same cluster are merged so that highly similar 
transcripts belonging to the same cell are combined and their counts added together.
This is done to correct for the production of spurious alternative assemblies 
produced by SPADES within each cell's assembled transcriptome.
4. a list is generated for each transcript of the cells in which they appear.
5. The lists is sorted by the abundance of the transcript within the cells.
6. the entries in the lists are marked by their relative abundance. If the number of 
reads aligned to the transcript in a cell is less than 10% of the largest amount reads 
aligned to that transcript within any cell, it is marked as being a potential 
contaminant. The idea is that if a transcript discovered in a cell is a contaminant it 
should have at least an order of magnitude fewer reads associated with it when 
compared with the cell it actually came from.
7. For each type (IGH,IGK,IGL) of IG transcript found within each cell, the largest 
unique (non-contaminant) transcript is picked to have potentially come from that cell. 
if a unique transcript cannot be found, the most highly expressed transcript is 
selected
8. If both a potential IGK and IGL are present within a cell, the unique transcript is 
selected. if both are unique or non-unique the most highly expressed transcript is 
selected unless either transcript has an abundance of at least  10% of the other.
9. After this process, most cells should have a single heavy chain and a single light 
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chain.
Visualization
All data visualization was done using Python/Numpy/Scipy/Matplotlib[] (Hunter 2007; 
Oliphant 2007; van der Walt, Colbert, and Varoquaux 2011; Jones, Oliphant, and 
Peterson 2001--). Schematics were drawn in Inkscape (https://inkscape.org/en/).
Data and Script Access
Raw data has been uploaded to the Sequence Read Archive (SRA) under the 
accessions 
PRJNA320873 (GM12878 Smartseq2 and Tn5Prime), PRJNA320902 (Mouse B2 
Cells), and
PRJNA415475 (Human CD27high CD38high). A UCSC genome browser track is 
available at 
https://genome.ucsc.edu/cgi-bin/hgTracks?
hgS_doOtherUser=submit&hgS_otherUserName=chkcole&hgS_otherUserSessionN
ame=TN5_Prime_Alignments
The Tn5Prime and CAGE Peak Caller and peak distance calculator are available at 
https://github.com/chkcole/Peak-Calling. All other Scripts are available upon request.
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Aim 3: Repertoire Sequencing Using the Oxford Nanopore
Abstract
Repertoire sequencing is a form of RNAseq specific to immunoglobulin transcripts. 
Over time, improvements have been made to this assay which have dramatically 
increased the breadth, depth, and overall accuracy of the resulting data. However, 
repertoire sequencing still requires a separate library preparation and sequencing 
steps independent of and in addition to the standard PolyA-specific RNAseq one 
might want to do on an RNA sample. We propose that repertoires can be acquired 
as a byproduct of a general RNA sequencing protocol by using the Rolling Circle to 
Concatemeric Consensus(R2C2) (Volden et al. 2018) method on lymphocyte-derived
RNA. We show that the repertories derived from this method are comparable to 
specialized repertoire sequencing approaches and can be achieved at no additional 
cost to the experimenter.
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Introduction
Antibodies are proteins generated exclusively by B cells whose primary purpose is to
bind to pathogens, disabling them and marking them for destruction by the immune 
system. During B cell maturation, each antibody gene(Heavy, Kappa or Lambda) is 
produced through a process called V(D)J recombination whereby a single Variable, 
Diversity, and Joining gene segment is randomly selected and recombined, along 
with the addition of non-template nucleotides, to create a gene unique to that cell. 
This process is what allows the adaptive immune system to generate protection 
against nearly any pathogen it might encounter.
Before the advent of high-throughput sequencing, antibodies were characterized by 
Sanger sequencing of cloned antibody genes or cDNA. Cloning requires the isolation
of a pure DNA template, so early studies were done almost exclusively on 
monoclonal B cell cancers. Even when all the necessary materials were present this 
method was slow and laborious. Indeed, some of the earliest studies of V segment 
diversity were the product of only a few dozen heavy or light chain sequences. With 
the invention of PCR and high-throughput sequencing came the ability to assay 
millions of discrete DNA molecules. In 2009 a method for sequencing antibody 
repertoires from zebrafish using the Roche 454 platform was published. Heavy chain
Amplicons were generated from rna using primers specific to the first framing region 
of the V segment and the constant region. These amplicons were used as the 
template for a 2x230 bp run which, in zebrafish, were long enough to cover the entire
V segment, allowing the entire heavy chain to be reconstituted through overlap 
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merging of the paired reads. Since then improvements to the protocol have been 
made, most notably the inclusion of UMIs into the read which result in the generation
of higher-accuracy antibody transcript sequences as well as more accurate 
quantification of antibody expression.  Nevertheless, amplicon-based repertoire 
sequencing has several experimental and informatic shortcomings such as the lack 
of an effective heavy/light chain pairing method in bulk samples, inability to 
distinguish between membrane and secreted antibodies, and the fact that the use of 
V and C segment primers can result in under or over-reporting of some antibodies. 
Two key technologies have emerged over the last five years which we believe will 
supplant dedicated repertoire-sequencing protocols, allowing for the production of 
high-quality repertoires as a byproduct of more general RNAseq experiments.
Nanopore Sequencing
Nanopore sequencing is a recently developed technology which permits the real-time
sequencing of single molecules of DNA of an arbitrary length. This technology was 
pioneered by Oxford Nanopore Technologies (ONT) and is mostly widely 
implemented in the form of a device called the ONT MinION. Unlike previous 
sequencing technologies amplification of the template strand is not required in order 
to determine the sequence. Instead the DNA is threaded through a protein channel 
embedded in lipid membrane with a current running across it. The DNA strand 
interrupts the flow of electrons through the pore, and will do so in a manner which 
can be used to identify the exact sequence which happens to be inside the pore at 
any given time. Thus, by threading a strand of DNA and measuring the change in 
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current, the current trance can be used to infer its sequence. One of the drawbacks 
of this technology is that there is significantly more uncertainty about the correctness 
of each base in the sequence compared with older sequencing technologies. For 
example, Illumina reads have a typical error rate of 1 in 1000 bases while the Oxford 
Nanopore produces errors at a rate around 1 in 10. Depending on the downstream 
applications for this sequence, a high frequency of errors could make the data 
difficult to analyze or entirely unusable.
In 2018 our lab published a method for improving the accuracy for nanopore reads 
called Rolling Circle Amplification to Concatemeric Consensus (Volden et al. 2018). 
DNA fragments are circularized by gibson assembly and amplified using phi29 and 
random primers. This produces pieces of DNA whose sequences are concatemers of
the original DNA fragment that was circularized. These pieces of DNA are 
sequenced and the sequence of the original fragments are inferred by identifying 
repeats in the sequence, splitting them, and then generating a consensus with the 
repeated sequences. Doing this we can generate sequences from the MinION with 
an average base error rate of 1 in 50.
The original motivation for the development of this method was transcript isoform 
analysis. Isoforms are transcripts produced by the same gene but with alternative 
splicing or transcription start sites. The choice of exons to include in a transcript can 
dramatically impact the function of the resulting protein. As such, the ability to 
quantify the relative expression of isoforms from the same gene is critical for 
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understanding a cell’s biology. Short-read RNAseq can’t be used to quantify isoforms
from complex genes because they are not long enough to span all of the exons and 
provide the needed connectivity information. Oxford Nanopore solves that problem 
by allowing the sequencing of entire transcripts. However, the base accuracy can 
make aligning regular nanopore reads imprecise and may cause the analysis 
software to miss or misidentify isoforms. In addition, a 1 in 10 error rate makes 
multiplexing libraries impractical since most demultiplexing strategies assume 
Illumina-level error rates with no insertions or deletions in the barcode sequence. 
R2C2 provided a method for sequencing full-length transcripts at an error rate low 
enough to accurately call isoforms and demultiplex pooled single cell libraries.
We concluded that, with enough sequencing depth, R2C2 could be used to 
characterize antibody repertoires of B cell-containing samples without any steps in 
the library creation process. Indeed, we proposed these repertoires would be a 
byproduct of a non-selective RNA sequencing experiment. In order to test this 
hypothesis we generated libraries from Human PBMC-derived RNA (Sample 23_2) 
using R2C2 and a conventional antibody-repertoire sequencing protocol and 
compared the results. We also included previously published data using the TMI-seq 
approach as part of the analysis (Cole et al. 2016).
Results
R2C2
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RNA was extracted from the PBMCs resulting in 235.6ng RNA /ul in 30ul of H2O. 
cDNA was generated from 4 ul of RNA using  a Oligo-dT primer and template-
switching oligo followed by ISPCR amplification for 12 cycles resulting in 8ng of 
cDNA/ul in 20ul. 40ng of cDNA was circularized by gibson assembly using DNA 
splints complementary to the ends of the cDNA molecule and the reactions were 
treated with a cocktail of exonuclease to remove uncircularized cDNA. The circles 
were SPRI cleaned and eluted in 40ul. The circularized cDNA was used as the input 
for four 50ul Rolling-Circle Amplification reactions using phi29 and random 
hexamers. These reactions were digested with T7 endonuclease and size selected 
on a gel to remove DNA less than 10kb long. This produced 65ng/ul in 100ul of H2O.
This DNA was used as the input for four LSK109 ligation library preps (1ug per 
library) and sequenced on four flowcells using the Oxford Nanopore MinION, 
generating 16.6 million raw reads. Consensi were called from these reads as 
previously described (Volden et al. 2018), generating 10.3 million consensus reads. 
These were then aligned to the hg38 genome with all alternative assemblies 
removed using minimap2 using the splice-aware mode, aligning 99.96% of the reads
(Li 2018). Putative antibody transcripts were collected by extracting reads which 
aligned on chromosome 14 between positions 105,536,018 and 106,883,485. This 
results in a set of 15171 reads of which 12864 could be successfully annotated by 
IGblast (Ye et al. 2013). V segment alleles and recombination rates were calculated 
for transcripts with either an IgM or IgD isotype which indicate that an antibody 
belongs to a naive B cell and is unlikely to contain significant amounts of somatic 
hypermutation.
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Antibody Repertoires
The same pool of RNA used for the R2C2 experiments was used to sequence 
standard Heavy chain repertoire libraries (Vollmers et al. 2013). This produced 
[INSERT RAW PAIRED READS HERE] which were used to generate 49563 merged
reads which covered the entire variable region and enough of the constant region to 
call isoforms. Of these, 48899 were successfully annotated by IgBlast.
V segment analysis
We determined the validity of our heavy chain sequences by examining the 
distribution of CDR3 lengths as well as the pattern of somatic hypermutations 
present in the V segments. CDR3 lengths follow a well established pattern: Their 
nucleotide length is generally a multiple of three and they are between 21 and 81 
bases long. The CDR3 sequence is determined by locating the amino acid motifs, 
[FY] [FHVWY] C [ADEGIKMNRSTV] at the 3’ end of the V segment and W[GAV] in 
the J segment. The location of these motifs determines the start and end of the 
CDR3. A histogram of the CDR3 lengths for the repertoire, TMIseq and R2C2 
antibody reads can be seen in figure 1. They have a median CDR3 length of  42, 45, 
and 45 nucleotides respectively. Which is in agreement with previously published 
reports on CDR3 length for heavy chains.
In order to estimate the V segment recombination rate from the disparate data sets 
we only considered heavy chains with an IgM or IgD Isotype. The results of the 
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comparison can be seen in figure 2. The results indicate significant disagreement 
between the three different methods for the recombination rate of the V segments as 
well as the number and type of alleles. Even accounting for the higher error rate of 
the R2C2 method, there clearly exists V segment alleles which are dominant in the 
R2C2 data set but almost entirely absent in the other two. Much of this is likely due 
to the fact that the repertoire sequencing protocol uses a priming site in FR2 and will 
be unable to detect alleles with polymorphisms in FR1, CDR1, or the leader exon. In 
addition, it is likely that the primers will have different efficiencies for different V 
segments, possibly overrepresenting some recombination events while suppressing 
others. We see this same pattern in play when examining the isotype abundance in 
figure 3. In the R2C2, nearly 75% of all antibody transcripts are IGHA, while in the 
TMIseq data it’s only a third. And,  just like with the V segments, the TMI-seq and 
repertoire sequencing protocol prime off of the constant region in order to amplify 
antibody transcripts.
Fig 1. Histograms of the CDR3 lengths for antibody heavy chain transcripts detected 
in S23_2 RNA using three different methods: R2C2, TMIseq, and a conventional 
repertoire sequencing protocol.
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Figure 2.  A bar chart comparing V segment recombination rates for R2C2, TMI-seq 
and a standard repertoire sequencing protocol. Bars are colored by allele.
Figure 3. Pie chart of the heavy chain isotypes detected by R2C2, TMIseq, and a 
conventional repertoire sequencing protocol.
Methods
RNA Purification
Whole blood was collected from a fully consented human volunteer at the UCSC 
Student Health Center. PBMCs were isolated from Whole Blood Sample 23_2 by 
Ficoll-gradient and cryopreserved in DMSO( approximately 10 million live cells per 
tube) using liquid nitrogen (vapor phase). A single tube of PBMCs was defrosted and
washed twice with 37C 1XPBS, spinning at 500g for 5 minutes in between washes. 
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500ul of trizol was added to the cell pellet and the whole volume was transferred to a
1.5ml tube. The cells were lysed for 5 minutes and 100ul of chloroform was added. 
The tube was shaken until the mixture acquired a pink, opaque hue. The reaction 
was allowed then allowed to sit for 2 minutes. The reaction was then spun at full 
speed in a microcentrifuge for 15 minutes at 4C. The aqueous layer was pipetted off 
and an equal volume of 70% Ethanol was added. The Qiagen RNAeasy mini prep kit
was used, starting from section #2 in the instruction booklet, following the directions 
for purifying RNA. The RNA  was eluted in 30ul of H2O, the concentration was 
measured with nanodrop, and aliquoted into individual PCR tubes and stored at -
80C. The results from this procedure when tested on the nanodrop where 235.6ng of
RNA per microliter of H2O. 
cDNA
In order to generate enough cDNA for circularization we generated two separate 
reactions and then pooled them together at the end. First, 2ul of RNA at ~235.6ng/ul 
were combined with 1ul of unprotected oligo dT and 1 ul of dNTPs in a thin-walled 
PCR tube and heated to 72C for 5 minutes using a thermocycler and then 
immediately placed on ice. To this reaction, 2ul of 5x Smartscribe buffer, 1 ul DTT, 
0.3ul of Smartscribe TSO, 1ul of Smartscribe enzyme, 0.25ul of Superase_IN, and 
1.45ul of H2O were added. The reactions were then heated to 42C for 1 hour, and 
then 70C for 5 minutes. The two 10ul reactions were then combined and 1ul of 10um
ISPCR(Smartseq2) primer, 1 ul of Lambda Exonuclease(NEB), 1ul RNAseA, and 
25ul of 2X Kappa master mix were added for a total volume of 50ul. The reaction 
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was then underwent PCR(37C 30 minutes, 95C 0:30 seconds, 12 cycles: 98C 20S; 
67C 15S; 72C 10 minutes, and then held for 4C). The reaction was then purified 
using a .85:1 SPRI purification ratio and eulted in 20ul of H2O.
Circularization
In order to circularize the cDNA we use double-stranded DNA splints complementary
to the end of our cDNA that can undergo gibson assembly. In one PCR tube, 23ul of 
H2O, 25ul of Kappa 2X master mix, 1ul of UMI_Splint_ISPCR 100uM, and 
UMI_splint_reverse 100uM were added then cycled(95C 3 minutes, 98C 1 minute, 
62C 1 minute, 72C 6 minutes). The reaction was then cleaned with the zymo select-
a-size cleanup protocol for single-size selection, but in the buffer preparation add 
85ul of 100% EtOH to 500ul of select-a-size DNA binding buffer. It was eluted in 20ul
of buffer EB (elution buffer) and the concentration measured with qubit. For the 
gibson assembly reaction we combined an approximately equal mass of splint to 
cDNA. In a single PCR tube we added 0.2ul of Splint(210ng), 5ul of cDNA(8ng/ul), 
4.8ul of H2O, and 10ul of NEBuilder 2X Master Max. This reaction is then incubated 
for 50C for 60 minutes. To this reaction we added 5ul of NEBuffer 2, 16ul H2O, 3ul 
Exonuclease I, 3ul of Exonuclease III, and 3ul of Lambda Exonuclease. This reaction
is then incubated 37C for 16hr followed by a heat inactivation step of 80C for 20 
minutes. The reaction was then purified with 0.8:1 SPRI beads and eluted in 40ul of 
H2O. in order to generate enough DNA for multiple library preps, we created four 
separate RCA reactions which were then combined at the end. For each reaction we 
combined in a PCR tube 5ul of Phi29 Buffer(NEB, 10X), 1ul of Phi29 Polymerase, 
2.5ul dNTP(10nM), 2.5ul Random hexamer primers(exo resistant, 10uM), 10ul of 
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circularized DNA from the previous reaction, and 29ul of H2O. The tube was 
incubated for 30C overnight. The four 50ul reactions were combined into two 100ul 
reactions. To each tube 2.5ul of T7 was added and the tube incubated at 37C for 2 
hours, agitating occasionally. The reactions were SPRI purified using a 0.5:1 ratio 
and eluted in 50ul of H2O. The DNA concentration was measured as 65ng/ul using 
qubit.
R2C2 Sequencing:
One microgram of size-selected and purified DNA was used as the basis for a 1D 
ligation-based library prep and then sequenced for 48 hours using the Oxford 
Nanopore MinION. This was done 4 times to produce the data set of interest.
Repertoires
In a single PCR tube, 1ul of RNA at 235ng/ul, 8.5ul of H2O, 2ul of IgH_RT primer 
mix, and 1ul of dNTP were added and heated to 72C for 5 minutes and then 
immediately placed on ice. To this reaction, 4ul of 5X Smartscribe buffer, 2ul of DTT, 
1ul of Superase_IN, and 0.5ul of Smartscribe polymerase were added. The reaction 
was then heated to 42C for 1 hour followed by 70C for 5 minutes. To this reaction 
was added 10ul 5X Phusion buffer, 1ul IgH_C_pool nm, 1ul IgH_V_pool nm, 1ul 
dNTPs 10um, 15ul H20, 1.5ul DMSO, and 0.25ul Phusion Polymerase. The reaction 
was then cycled(2 cycles of: 98 °C for 3 min, 52 °C for 2 min, 72 °C for 4 min) and 
then purified using a Zymo Select-A-Size Clean and Concentrator column with a 
300bp cutoff. The DNA was eluted in 23ul of buffer EB.In a single PCR tube was 
added the 23ul of cDNA, 25ul of 2X Kappa Master Mix, 1ul of Nextera A primers 
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(10nM), and 1ul of Nextera B primers (10nM). The reaction was cycled (95°C for 3 
minutes, 25 cycles of: 98°C 20 secs; 63°C for 30 secs;72°C for 2 min, final extension
of 72°C for 5 minutes). A final purification step was performed using a 1:0.75 sample 
to SPRI bead purification and the product was eluted in a final volume of 20uL. The 
sample was then ran on a 2% agarose gel and quantified by Qubit fluorometer 
(Invitrogen) to verify quantity and quality of the library prior to sequencing. The 
samples were sequenced on a MiSeq 2 x 300 run.
Conclusion 
 During the course of my studies I tackled several problems in the field of antibody 
genetics and succeeded in solving two of them. The TMIseq method allows the 
assembly of full-length antibody transcripts from molecularly-index subreads. This 
method solved the issue of full-length transcript sequencing, allowing people to 
accurately assign V segment allele and isotype to individual transcripts. The 
Tn5prime method is a simple method for sequencing the 5’ ends of RNA transcripts. 
In addition, it allows people to pair full-length heavy and light chains in individual B 
cells. I demonstrated that the R2C2 method can be used to sequence heavy and 
light chain transcripts with enough accuracy to confidently assign V segment alleles 
and isotypes. The preliminary data indicates substantial disagreement with 
previously published methods, raising questions about the validity of V segment 
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recombination rate estimation from primer-based assays.
I propose that the R2C2 method could one day be used as a substitute for repertoire-
specific sequencing protocols when assaying immune function. It captures full-length
transcript information for antibodies, T cell receptors, and every other polyA 
transcript present in the sample. It is also accurate enough to assign transcripts to 
specific isoforms and alleles and, as such, is a substantially more powerful method 
than assays which use primers to target only specific transcripts. I also propose that 
because the R2C2 method does not introduce bias into the data by using DNA 
primers that we can accurately measure the true recombination rates for specific 
gene segments, perhaps revealing hitherto unknown biology about VDJ 
recombination.
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